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ABSTRACT
Purpose: To examine the effects of 28 days of β-hydroxy-β-methylbutyrate free acid (HMB) and
high-intensity interval training (HIIT) on maximal oxygen consumption (𝑉O2peak), ventilatory
threshold (VT), respiratory compensation point (RCP) and time to exhaustion (Tmax) in collegeaged men and women. Methods: Healthy men and women (n=34, age and 𝑉O2peak= 22.7+3.1yr
and 39.3+5.0 mL.kg-1.min-1, respectively) participated in this study. All participants completed a
series of tests prior and subsequent to treatment. A maximal oxygen consumption test was
performed on a cycle ergometer to assess 𝑉O2peak, Tmax, VT, and RCP. The peak power output
(Ppeak), power at VT (PVT) and power at RCP (PRCP) were also recorded from this test.
Twenty-six subjects completed 12 HIIT (80-120% maximal workload) exercise sessions
consisting of 5-6 bouts of a 2:1 minute cycling work to rest ratio protocol over a four-week
period, while eight served as controls (CTL). In double-blind fashion, the HIIT groups were
assigned into either a placebo (HIIT) or 3g per day of HMB (HMB-HIIT). Body composition
was measured with dual energy x-ray absorptiometry (DEXA). Outcomes were assessed by
ANCOVA with posttest means adjusted for pretest differences. Results: The HMB-HIIT
intervention showed significant (p<0.05) gains in 𝑉O2peak, VT, and PVT versus the CTL and
HIIT group. Both HIIT and HMB-HIIT treatment groups demonstrated significant (p<0.05)
improvement over CTL for Ppeak, Tmax, RCP, and PRCP with no significant difference between
the treatment groups. There were no significant differences observed for any measures of body
composition. An independent-samples t-test confirmed that there were no significant differences
between the training volumes for the HIIT and HMB-HIIT groups. Conclusion: These findings
suggest that the addition of HMB supplementation may result in greater changes in 𝑉O2peak and
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VT than HIIT alone. Therefore, in college-aged men and women, the use of HMB
supplementation may enhance the benefits of HIIT on aerobic performance measures.
Keywords: High-Intensity Interval Training, β-Hydroxy-β-Methylbutyrate, Aerobic, Endurance,
𝑉O2peak, Respiratory Compensation Point, Ventilatory Threshold
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CHAPTER I
High-intensity interval training (HIIT) has become a popular training modality over the
past 10 years due to its potential benefits in athletes, untrained individuals, and clinical
populations. HIIT consists of repeated bouts of short to moderate duration exercise completed at
intensities greater than the anaerobic threshold, interspersed with brief periods of low intensity or
passive rest. The salient features of HIIT over constant rate aerobic training (CRT) are shorter
training periods and the reported improvements of both the oxidative and glycolytic systems
(Laursen & Jenkins, 2002; Perry, Heigenhauser, Bonen, & Spriet, 2008).
HIIT is designed to repeatedly stress the body physiologically, resulting in chronic
adaptations and improved metabolic efficiency (Jenkins & Quigley, 1993; Laursen, Shing,
Peake, Coombes, & Jenkins, 2005). Specifically, these adaptations include altered skeletal
muscle substrate utilization and improved respiratory control sensitivity resulting from increased
mitochondrial density (Jacobs et al., 2013). Helgerud et al. (2007) reported that an eight-week
running HIIT program improved 𝑉O2max and TTE more than CRT in moderately trained males.
Further, Smith et al. (2009) reported a 9% to 11% increase in 𝑉O2peak and ventilatory threshold
(VT) values after only 3-weeks of HIIT on a cycle ergometer using college age males. HIIT,
therefore, is a time-efficient exercise strategy that has shown consistent positive results following
relatively short training programs.
The branched-chain amino acid, leucine, has shown to be the key contributor for muscle
protein synthesis and may play a role as a substrate during this process (Churchward-Venne et
al., 2014). As such, dietary supplementation of leucine and its metabolites have been
demonstrated to provide anabolic or anti-catabolic effects on lean body mass during training or
periods of energy imbalance (Carbone, McClung, & Pasiakos, 2012; Katsanos, Kobayashi,
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Sheffield-Moore, Aarsland, & Wolfe, 2006; Norton & Layman, 2006). Ingestion of one of these
metabolites, β-hydroxy-β-methylbutyrate (HMB), has been suggested to provide similar benefits
to those of leucine with regard to muscle protein synthesis (Wilkinson et al., 2013). Additional
investigation with HMB and resistance training in humans has shown improvement in muscle
mass and strength in both younger and older samples (Flakoll et al., 2004; Nissen et al., 1996; J.
R. Stout et al., 2013; G. J. Wilson, Wilson, & Manninen, 2008). Recently, scientists have
suggested HMB may enhance the benefits of aerobic training. Knitter et al. (2000) proposed that
HMB might improve intense aerobic training by attenuating skeletal muscle damage and
accelerating recovery between training bouts. In support, Knitter et al. (2000) examined the
effect of three grams of HMB or placebo per day in trained endurance athletes for six weeks.
Following the training and supplementation period, blood markers of muscle damage, creatine
phosphokinase (CPK) and lactate dehydrogenase (LDH), were measured in response to a 20-km
race. Immediately and 24-hours post-run, LDH and CPK levels were 10.5% and 17% lower in
the HMB supplemented group, respectively. The results from Knitter et al. (2000) suggested that
HMB supplementation may attenuate some of the muscle damage often observed with endurance
training, possibly reducing the incidence of overtraining and allowing for greater training
adaptations.
The physiological mechanisms influenced through HMB supplementation and training
may also confer improvements in exercise performance. In support, Vukovich and Dreifort
(2001) examined the effect of 3grams of HMB or placebo per day for 14 days in elite cyclists
while average training volume was 300 miles per week. In response to only the HMB condition,
the cyclists demonstrated a significant increase in peak oxygen consumption rate (𝑉O2peak) and
an increase in the onset of blood lactate accumulation during a graded exercise test. Vukovich
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and Driefort (2001) suggested that changes in maximal and submaximal performance after HMB
supplementation may be due to both the attenuation of protein breakdown and the augmentation
of mitochondrial protein synthesis resulting in greater oxidative energy capacity.
More recently, Lamboley et al. (2007) examined the effect of 5 weeks of HMB
supplementation and HIIT on a treadmill in physically-active college students. Specifically, they
measured changes in 𝑉O2max, VT and respiratory compensation point (RCP) during a graded
exercise test at baseline and post training. The 5 weeks of running HIIT was completed 3 times
per week on a 1% graded treadmill and participants supplemented 3 grams per day of HMB or
placebo. The results of their investigation demonstrated significant increases in 𝑉O2max, VT
and RCP in both treatment groups from the HIIT, however, HMB resulted in a 19% to 45%
greater increase in all metabolic variables. The authors suggested that HMB may have
attenuated the muscle damage often observed from running and might have accelerated recovery
between training bouts. Further, HMB supplementation could have enhanced the training
stimulus of HIIT on VT and RCP by increasing mitochondrial biogenesis, thus improving
oxidative energy capacity and efficiency (Stancliffe, 2012).
It appears that HMB supplementation is most effective during muscle damaging exercise
(J. M. Wilson, Lowery et al., 2013). Lamboley et al. (2007) indicated that they specifically
selected running to induce delayed onset muscle soreness, a non-invasive indicator of muscle
damage. However, to date, no one has examined the effect of HMB supplementation while
undergoing a chronic HIIT program on a cycle ergometer. If muscle damage is needed to
observe the potential benefits of HMB supplementation, then HIIT training on a cycle ergometer,
which produces much less muscle damage (Koller et al., 1998) than running, may provide no
additional benefit. Therefore, the purpose of this study was to examine the effects of chronic (4-
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weeks) supplementation in combination with cycle ergometry HIIT on endurance performance
measures in active college age men and women.
Hypotheses
1. It was hypothesized that four weeks of HMB supplementation combined with HIIT
would significantly increase 𝑉O2peak, VT, RCP and time to exhaustion in active
individuals
2. It was hypothesized that four weeks of HIIT alone would be significantly increase
𝑉O2peak, VT, RCP and time to exhaustion.
3. It was hypothesized that four weeks of HMB supplementation combined with HIIT
would increase 𝑉O2peak, VT, RCP and time to exhaustion in recreationally trained
individuals significantly more than HIIT alone.
4. It was hypothesized that four weeks of HMB supplementation combined with HIIT
would alter body composition in active males and females.
Theoretical Assumptions
1. Subjects accurately answered the medical history and activity questionnaire.
2. All subjects gave maximal effort when performing the 𝑉O2peak test.
3. Participants consumed a similar diet prior to each experimental testing session.
4. Participants were well-rested prior to each experimental testing session.
5. Participants abstained from all other supplements was maintained throughout the testing
and training period.
6. Participants gave a maximal effort during each training session.
7. Participants were compliant with the supplementation protocol.
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8. Participants were unable to identify whether they were taking the supplement or the
placebo.
Statistical Assumptions
1. The population from which the samples are drawn is normally distributed.
2. The sample was randomly selected and the treatment order was randomly assigned.
3. The data met the assumption of sphericity. This requires that the repeated measures data
demonstrate both homogeneity of variance and homogeneity of covariance.
Limitations
1. Due to the intensity of the exercise involved and the length of the study, participant
withdrawal was inevitable.
2. The main recruiting mechanism of recruitment was in-class announcements through the
College of Education and Human Performance courses, subject selection not truly
random, which could affect internal validity and may impact generalizability.
3. The sample was made up of volunteers, therefore, not meeting the underlying
assumptions of random selection.
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CHAPTER II
Review Of Literature
High-intensity interval training (HIIT) consists of repeated bouts of short to moderate
duration exercise completed at an intensity greater than the anaerobic threshold, interspersed
with brief periods of low intensity or passive rest. HIIT is designed to repeatedly stress the body
physiologically, resulting in chronic adaptations and improving metabolic and energy efficiency
significantly faster and greater than traditional constant rate aerobic training (Helgerud et al.,
2007; Jenkins & Quigley, 1993; Laursen et al., 2005). Specifically, these adaptations may
include a change in skeletal muscle substrate utilization and improved respiratory control
sensitivity, resulting from increased mitochondrial density (Jacobs et al., 2013).
A few scientists have suggested that the metabolite of leucine, β-hydroxy-βmethylbutyrate (HMB) may enhance the benefits of aerobic training (Knitter, Panton,
Rathmacher, Petersen, & Sharp, 2000; Lamboley, Royer, & Dionne, 2007; Vukovich & Dreifort,
2001). Knitter et al. (2000) proposed that HMB may improve intense aerobic training by
attenuating skeletal muscle damage and accelerating recovery between training bouts leading to
greater training adaptations. In support, Vukovich and Driefort (2001) examined the effect of
3grams of HMB or placebo per day for 14 days in elite cyclist while average training volume
was 300 miles per week. Only during the HMB supplementation period, did the cyclist
demonstrate a significant increase in peak oxygen consumption rate (𝑉O2peak), and an increase
in the onset of blood lactate accumulation during a graded exercise test. Further, Lamboley et al.
(2007) examined the effect of 5 weeks of HMB supplementation and HIIT on a treadmill in
physically-active college students. Specifically, they measured changes in 𝑉O2max, VT and
respiratory compensation point (RCP) during a graded exercise test at baseline and post training.
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The 5 weeks of running HIIT was completed 3 times per week on a 1% graded treadmill and
participants supplemented 3 grams per day of HMB or placebo. The results demonstrated
significant increases in 𝑉O2max, VT and RCP in both treatment groups from the HIIT; however,
HMB resulted in a 19% to 45% greater increase in all metabolic variables. To date, research
suggests that HMB supplementation in conjunction with endurance training may improve
maximal and submaximal performance, not only by attenuating protein breakdown, but may be
augmenting the mitochondrial protein synthesis for greater oxidative energy capacity (Knitter et
al., 2000; Lamboley et al., 2007; Vukovich & Dreifort, 2001).
Effects of High Intensity Interval Training VO2peak
Talanian, Galloway, Heigenhauser, Bonen, Spriet (2007)
Two weeks of high-intensity aerobic interval training increases the capacity for fat
oxidation during exercise in women
The aim of this study was to examine seven HIIT sessions over 2 week on skeletal muscle fuel
content, mitochondrial enzyme activities, fatty acid transport proteins, V̇ O2 peak, and whole body
metabolic, hormonal, and cardiovascular responses to exercise. Eight female participants
performed a V̇ O2 peak test and a 60-min cycling trial at ∼60% V̇ O2 peak before and after training.
Each HIIT session consisted of ten 4-min bouts at ∼90% V̇ O2 peak with 2 min of rest between
intervals. Training increased V̇ O2 peak by 13%. After HIIT, plasma epinephrine and heart rate
decreased during the final 30 min of the 60-min cycling trial at ∼60% pre-training V̇ O2 peak.
Exercise whole body fat oxidation increased by 36%, and net glycogen use was reduced during
the post-training 60-min cycling trial. HIIT significantly increased muscle mitochondrial βhydroxyacyl-CoA dehydrogenase 31.8% and citrate synthase 19.88% after training. In addition,
total muscle plasma membrane fatty acid-binding protein content increased significantly (25%),
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whereas fatty acid translocase/CD36 content was unaffected after HIIT. In summary, seven
sessions of HIIT over 2 wk at a training intensity of ~90% VO2max was sufficient to improve
VO2peak and resulted in increases in whole body and skeletal muscle capacity for fatty acid
oxidation during exercise in moderately active women.
Duffield, Edge, Bishop (2006)
Effects of high-intensity interval training on the VO2 response during severe exercise
The purpose of this study was to examine the effect of high-intensity interval training on the VO2
response during severe, constant-load exercise. Prior to, and following training, 10 females
performed a graded exercise test to determine VO2peak and lactate threshold and a 6 min cycle
test at the pre-training VO2peak intensity. Training involved high-intensity intervals (2 min
work, 1 min rest) performed 3× week for 8 weeks. The training protocol involved a periodized
increase in volume and intensity over the 8-week program, with a taper during the final week to
simulate the style of true athletic competition training. Individual programs were tailored to
participants using a percentage of the lactate threshold measured during the GXT. This training
protocol resulted in significant improvements in VO2peak, 20.87%, power at VO2  max, 20% and
power at LT, 20.35%. In conclusion, a severe-intensity interval-training program significantly
increased VO2 peak and power at both VO2peak and the lactate threshold in active females
without altering the speed of the VO2 response to severe-intensity exercise. The greater VO2
response also decreased the accumulated oxygen deficit, which resulted in a significantly
reduced reliance on anaerobic metabolism at the same absolute intensity. Therefore, training at
high intensities can increase oxygen consumption at maximal exercise intensities without
slowing the speed of the aerobic response.
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Helgerud, Høydal, Wang, Karlsen, Berg, Bjerkaas, Simonsen, Helgesen, Hjorth, Bach, Hoff
(2007)
Aerobic High-Intensity Intervals Improve 𝑽O2max More Than Moderate Training
The primary purpose of this study was to compare the effects of aerobic endurance training at
different intensities and with different methods matched for total work and frequency. To
measure these responses, VO2max, stroke volume, blood volume, lactate threshold, and running
economy were examined. For this study, 40 healthy, nonsmoking, moderately trained male
subjects were randomly assigned to one of four groups. The first group performed a continuous
run at 70% heart rate max for 45 min. The second group performed a continuous run at lactate
threshold which was set at 85% heart rate max for 24.25 min. The third group, an interval run
group, performed 47 repetitions of 15-s intervals at 90– 95% heart rate max with 15 s of active
rest at 70% heart rate max between each sprint. The final group trained a 4x4-min interval
training at 90–95% heart rate max with 3 min of active rest at 70% heart rate max between each
interval. All four training protocols were performed 3 times per week for 8 weeks. HIIT
resulted in significantly increased VO2max compared with continuous training intensities. The
percentage increases for the 15/15 and 4 × 4 min groups were 5.5 and 7.2%, respectively,
reflecting increases in VO2max from 60.5 to 64.4 mL·kg-1·min-1 and 55.5 to 60.4 mL·kg-1·min-1.
Stroke volume also increased significantly by approximately 10% after interval training. The
main finding of this study is that HIIT is significantly more effective than training at lactate
threshold or continuous exercise even when performing the same total work for improving
VO2max. The authors also state that improvements in VO2max seem to be dependent on initial
fitness level and type of exercise normally performed by the individual; individuals who
performed short, intense burst-style, similar to football, saw no change in VO2max, while youth
soccer players saw a 5-10% increase, and untrained individuals saw a 17.9% increase. The fact
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that stroke volume also increased significantly in the HIIT group leads the authors to suggest that
stroke volume, as a component of cardiac output, is a key component of cardiorespiratory gains
seen with this training regimen.
Smith, Walter, Graef, Kendall, Moon, Lockwood, Fukuda, Beck, Cramer, Stout (2009)
Effects of β-alaninesupplementation and high-intensity interval training on endurance
performance and body composition in men; a double-blind trial
The focus of this study was to evaluate the effects of combining β-alanine supplementation with
HIIT on endurance performance and aerobic metabolism in recreationally active college-aged
men. Forty-six men were tested for VO2peak, time to fatigue, ventilatory threshold, and total
work done at 110% of pre-training VO2peak. In a double-blind fashion, all subjects were
randomly assigned into one either a placebo or β-alanine group and engaged in a total of six
weeks of HIIT training consisting of 5–6 bouts of two-minute intervals with one-minute rest
periods. Training followed a fractal periodized plan, which began at an intensity of 90% of peak
power achieved during the pretesting VO2peak test and progressed in an undulating manner,
reaching a maximum of 115% of peak power. Significant improvements in VO2peak, time to
exhaustion, and total work done after three weeks of training were observed with no significant
differences between the groups. The findings of this study, which are relevant to the current
investigation, are that HIIT significantly increased time to exhaustion and is an effective tool that
induces significant aerobic improvements with a relatively short period of training.
Jourkesh, Ahmaidi, Keikha, Sadri, Ojagi (2011)
Effects of six weeks sodium bicarbonate supplementation and high-intensity
interval training on endurance performance and body composition
The main aim of this study was to examine the effects of combining sodium bicarbonate
supplementation with HIIT on endurance performance and aerobic metabolism. Thirty-six
recreationally active college aged men gave their informed consent and volunteer to participate
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in the study. VO2peak, time to fatigue, ventilatory threshold, and total work done at 110% of
pre-training VO2peak were assessed. In double-blind conditions, all subjects were randomly
assigned into one either a placebo or sodium bicarbonate group. All subjects supplemented four
times per day (total of 200 mg/day) for the first 21-days, followed by two times per day (100
mg/day) for the subsequent 21 days, and engaged in a total of six weeks of HIIT training
consisting of 5-6 bouts of a 2:1 minute cycling work to rest ratio. The results suggest that the
significant improvements in VO2peak, time to exhaustion, and total work after three weeks of
training were observed. The findings highlight the use of HIIT to induce significant aerobic
improvements is effective and efficient. Chronic sodium bicarbonate supplementation may
further enhance HIIT, improving endurance performance and lean body mass.
A Review of Respiratory and Metabolic Thresholds During Exercise
Beaver, Waserman, Whipp (1986)
A new method for detecting anaerobic threshold
The purpose of this study was to examine the relationship between VO2 and CO2 versus the VE
to determine how each reacts to a graded exercise test and to relate those responses to
physiological responses within the body. Excess CO2 is generated when lactate is increased
during exercise because it [H+] is buffered primarily by bicarbonate. The researchers have
developed a method to detect the anaerobic threshold, using computerized regression analysis of
the slopes of the CO2 uptake (VCO2) vs. O2 uptake (VO2) plot, which detects the beginning of
the excess CO2 output generated from the buffering of H+ ions, termed the V-slope method.
From incremental exercise tests on 10 subjects, the point of excess CO2 output closely predicted
the lactate and bicarbonate thresholds. The mean gas exchange anaerobic threshold was found to
correspond to a small increment of lactate above the mathematically defined lactate threshold
[0.50 +/- 0.34 (SD) meq/l] and not to differ significantly from the estimated HCO-3 threshold.
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The mean VO2 at anaerobic threshold computed by the V-slope analysis did not differ
significantly from the mean value determined by a panel of six experienced reviewers using
traditional visual methods, but the anaerobic threshold could be more reliably determined by the
V-slope method. The respiratory compensation point, detected separately by utilizing the Vslope method to examine the minute VE vs. VCO2 plot, was consistently higher than the
anaerobic threshold (2.51 +/- 0.42 vs. 1.83 +/- 0.30 l/min of VO2). This V-slope method for
determining the anaerobic threshold and respiratory compensation point may detect the increased
CO2 production from buffering metabolic acid and may provide a more widely accepted and
applicable method for estimating metabolic thresholds.
Caiozzo, Davis, Ellie, Azus, Vandagriff, Prietto, McMaster (1982)
A comparison of gas exchange indices used to detect the anaerobic threshold
This study was designed to examine four commonly used ventilatory or gas exchange indices
and determine which may provide the most accurate and reliable detection of the anaerobic
threshold. Sixteen participants performed two graded exercise tests on a cycle ergometer to
volitional fatigue. After 4 min of unloaded cycling, the work rate was increased 20 W/min.
Ventilatory and gas exchange measurements were made every 30 sec throughout each test.
During one of the two tests, venous blood was also sampled every 30 sec for subsequent
determinations of blood lactate concentration. VE, VCO2, RER, VE/VO2 were used separately
to detect the anaerobic threshold. The anaerobic threshold determined from systematic increases
in lactate concentration was used as the criterion measure. Anaerobic threshold values were
found using VE(1.79 +/- 0.11), VCO2(1.74 +/- 0.11), RER(1.58 +/- 0.06), VE/VO2(1.84 +/0.11), and blood lactate (1.85 +/- 0.11 l/min)concentrations. The highest correlation between a
ventilatory or gas exchange anaerobic threshold and onset of blood lactate was found to be
VE/VO2 (r=0.93, P < 0.001). The VE/VO2 was also found to have the highest test-retest
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correlation for detection of the anaerobic threshold (r = 0.93, P < 0.001). Multiple correlational
analyses did not significantly enhance detection of the anaerobic threshold. The authors
identified five factors that favor using VE/VO2 to detect the anaerobic threshold: 1) it provides
the highest correlation with onset of blood lactate accumulation; 2) it resulted in the highest testretest correlation; 3) VE/VO2 is easily derived from standard ventilatory and gas exchange
measures; 4) VE/VO2 exhibits a tri-phasic pattern that qualitatively allows the investigator to
have more confidence in the determination of anaerobic threshold; and 5) the dual criterion
utilizing VE/VCO2 provides and more specific detection of the anaerobic threshold. Therefore,
the authors believe that the use of VE/VO2 for noninvasive detection of the anaerobic threshold
produces the most sensitive and reliable ventilatory or gas exchange index studied.
Meyer, Faude, Scharhag, Urhausen, Kindermann (2003)
Is lactic acidosis a cause of exercise induced hyperventilation at the respiratory
compensation point?
The aim of this study was to discover the role of pH changes in the onset of hyperventilation play
in incremental exercise. Five healthy participants completed a first ramp-like exercise test on a
cycle ergometer, and respiratory compensation point was determined from gas exchange
measurements in subjects. The first exercise served as a baseline test to determine the course
and degree of the pH decline and the normal ventilatory stress reaction. In the second test,
sodium bicarbonate was injected intravenously in small doses during a second, otherwise
identical, exercise test to offset blood acidification. In each subject sufficient compensation for
the acidosis, that is, a pH value constantly above 7.37, was attained during the second test. A
delay but no disappearance of the hyperventilation was present in all participants when compared
with the first test. The respiratory compensation point occurred on average at a significantly
(p = 0.043) higher oxygen uptake (+0.15 l*min–1) compared with the first test. This study
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demonstrates that the respiratory compensation point was delayed when exercise induced blood
acidosis was prevented by intravenously injecting bicarbonate. This experiment provides
evidence that changes in blood pH are involved in the initiation of the respiratory compensation
point. However, other physiological stimuli for hyperventilation seem to be present. Therefore,
it is concluded that exercise induced lactic acidosis is causally involved in the hyperventilation,
which starts at the respiratory compensation point. However, the authors cautioned that lactic
acidosis does not represent the only additional stimulus of ventilation during intense exercise.
Paterson, Friedland, Bascom, Clement, Cunningham, Painter, Robbins (1990)
Changes in arterial K+ and ventilation during exercise in normal subjects and subjects
with McArdle's syndrome
The goal of this study was to examine the relationship between VE, lactate and arterial plasma
K+ concentrations during incremental exercise in six normal subjects and in four subjects with
McArdle's syndrome who do not become acidotic during exercise. During the exercise test the
work rate was increased each minute by increments of 25W for the normal participants and 5W
for the participants with McArdle's syndrome until both groups reached the point of volitional
fatigue. This point was attained when a rating of perceived exertion of 19 was reached on the
Borg scale or when a pedal frequency of 60 rpm could no longer be maintained. Blood for
potassium analysis was sampled from the catheter into heparinized syringes at the end of each
minute of exercise and during the 10 min recovery period. In normal subjects, arterial plasma K+
rose to ca7 mM at the point of exhaustion. The time courses of the increases in VE, lactate and
arterial plasma K+ were all similar during the exercise period. Lactate reached its peak
concentration during the recovery from exercise when both VE and arterial plasma K+ were
returning to baseline levels. For the participants with McArdle's syndrome a non-linear
ventilatory response during incremental exercise was observed. Arterial plasma K+ was in this
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group was closely related to VE throughout exercise and recovery. Arterial pH in the McArdle's
syndrome participants increased from the onset of exercise, rather than remaining constant. At
all stages of exercise, the levels of VE and arterial plasma K+ concentrations were greater in the
participants with McArdle's syndrome than in the control group. The unique finding of this
study was that that the close relationship of hyperkalemia and VE during a graded exercise test
may contribute significantly to the drive to breathe—in both a normal population and in
individuals with McArdle’s syndrome for whom acid plays no role in ventilation during
exercise—and may stimulate hyperventilation during heavy exercise.
Effect of Training on Respiratory Compensation Point and Ventilatory Threshold
Oshima, Tanaka, Miyamoto, Wadazumi, Kurihura, Fujimoto (1998)
Effects of endurance training above the anaerobic threshold on isocapnic buffering phase
during incremental exercise in middle-distance runners
A study was performed to clarify the effects of endurance training above the anaerobic threshold
on the isocapnic buffering phase during incremental exercise in athletes. Eight middle-distance
runners performed a graded exercise test utilizing a modified version of the Bruce protocol.
After 6-months of HIIT and paced running training at levels above anaerobic threshold, VO2max
was significantly different from 60.1±5.7 to 64.7±5.5, a 7.65% increase. Anaerobic threshold
increased 4.9%, which although slight, showed a significant increase from pre-training. The
respiratory compensation point also saw significant and marked increase of 7.2% above the
baseline testing value. Although neither the slope of the first regression line below anaerobic
threshold nor that of the second line above anaerobic threshold calculated by V-slope analysis
was altered, the range of isocapnic buffering from anaerobic threshold to respiratory
compensation point was significantly extended from 24.8±5.9 to 28.1±6.0 after the 6-months of
training. In addition, the amount of change in VO2max after the 6-month training period was
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correlated with the change in isocapnic buffering (R=0.72, p<0.05). One drawback to the study
was that training was unstructured, individuals were allowed to train on their own with the
instruction to ensure that during interval training, sprints were performed in an “all out” effort.
The authors concluded that the degree of increased respiratory compensation point is larger than
that of anaerobic threshold after high-intensity endurance training at levels above anaerobic
threshold and that the range of isocapnic buffering may be an important factor in relation to the
increase in the maximal aerobic capacity of athletes.
Daussin, Zoll, Dufour, Ponsot, Lonsdorfer-Wolf, Doutreleau, Mettauer, Piquard, Geny, Richard
(2008)
Effect of interval versus continuous training on cardiorespiratory and mitochondrial
functions: relationship to aerobic performance improvements in sedentary subjects
The goal of the study was to determine the effects of continuous vs. HIIT training yielding
identical mechanical work and training duration on skeletal muscle and cardiorespiratory
adaptations in sedentary subjects. Eleven subjects (6 men and 5 women) were randomly
assigned to one of two 8-wk training programs in a cross-over design, separated by 12 wk of
detraining. V̇ O2max increased 9% after continuous training and 15% with HIIT), whereas only
HIIT was associated with faster V̇ O2 kinetics (τ: 68.0 ± 1.6 vs. 54.9 ± 0.7 s, P < 0.05) measured
during a test to exhaustion (TTE) and with improvements in maximal cardiac output (Qmax,
from 18.1 ± 1.1 to 20.1 ± 1.2 l/min; P < 0.01). Only HIIT training produced a significant
increase in skeletal muscle mitochondrial oxidative capacities (Vmax) which increased 36.4%
after the HIIT. Both training styles resulted in increased capillary density, with a two-fold higher
enhancement after continuous training (40%) than for the HIIT (21%). The gain of Vmax was
correlated with the gain of time to exhaustion and the gain of V̇ O2max with HIIT. The gain of
Qmax was also correlated with the gain of VO2max. The results of this study reveal that
endurance training programs with similar exercise duration and similar total mechanical
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workload but different O2 fluctuations, induce specific peripheral and central adaptations. In
particular, repeated fluctuations of O2 consumption during training sessions seem to be necessary
to improve muscular oxidative capacities. Together, these results provide a mechanistic
framework to explain the greater efficiency of interval type over continuous-type training on
endurance performance enhancement. Moreover, our observations suggest that enhancements of
muscular mitochondrial function are actively involved in the observed VO2max improvements.
Therefore, HIIT seems optimal in maximizing both peripheral muscle and central
cardiorespiratory adaptations, permitting significant functional improvement.
Effect of High-Intensity Interval Training on Body Composition
Tremblay, Simoneau, Bouchard (1994)
Impact of exercise intensity on body fatness and skeletal muscle metabolism
The present study was aimed at re-evaluating the hypothesis—that for a given level of energy
expenditure, individuals engaging in vigorous activities are leaner than those participating in less
intense activities and inactive people—by comparing the impact on body fatness of a program
including only aerobic exercise of moderate intensity versus a high-intensity exercise program.
The current study attempted to provide a mechanistic explanation for the potential difference in
fat loss between the two exercise programs. Therefore, they examined the impact of two
different modes of training on body fatness and skeletal muscle metabolism in young adults.
Twenty-seven men and women were assigned to either a 20-week continuous endurance training
program (8 men; 9 women) or a 15-week HIIT program (5 men; 5 women). The HIIT group
performed 25 30-minute sessions of continuous exercise at 70% of the maximal heart rate
reserve, which approximately corresponded to an intensity comparable to the intensity of the
individuals exercising in the continuous endurance training program. In addition, they
performed 19 short- and 16 long-interval sessions over a period of 1.5weeks. The mean

	
  

17	
  

estimated total energy cost of the continuous endurance training program was 120.4 MJ, whereas
the corresponding value for the HIIT program was 57.9 MJ. Despite its lower energy cost, the
HIIT program induced a more pronounced reduction in subcutaneous adiposity compared with
the continuous endurance training program. There was no significant change in body weight in
response to either the continuous endurance training or the HIIT program. Both programs
induced significant reductions in the suprailiac skinfold and the sum of three trunk subcutaneous
skinfolds. In addition, a significant decrease in the triceps, biceps, and subscapular skinfolds as
well as the sum of three limb skinfolds and the sum of the six skinfolds, was observed following
the HIIT program. When corrected for the energy cost of training, the decrease in the sum of six
subcutaneous skinfolds induced by the HIIT program was nine fold greater than by the
continuous endurance training program. Muscle biopsies obtained in the vastus lateralis before
and after training showed that both training programs similarly increased the level of the citric
acid cycle enzymatic marker. On the other hand, the HIIT program increased the activity of
muscle glycolytic enzymes, whereas a decrease was observed following the continuous
endurance training program. The enhancing effect of training on muscle 3-hydroxyacyl
coenzyme A dehydrogenase (HADH) enzyme activity, a marker of the activity of β-oxidation,
was significantly greater after the HIIT program. Although unable to explain the effect of
exercise intensity on energy balance, the authors speculate that following a vigorous exercise,
energy intake is either transitorily suppressed or increased to a lesser degree compared with that
following an exercise of low to moderate intensity. Additionally, it is also possible that vigorous
exercise has a greater enhancing effect on post-exercise energy expenditure than that of moderate
exercise. These results reinforce the notion that for a given level of energy expenditure, vigorous
exercise favors negative energy and lipid balance to a greater extent than exercise of low to
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moderate intensity. Moreover, the metabolic adaptations taking place in the skeletal muscle in
response to the HIIT program appear to favor the process of lipid oxidation.
Keating, Machan, O’Connor, Gerofi, Sainsbury, Caterson, Johnson (2014)
Continuous Exercise but Not High Intensity Interval Training Improves Fat Distribution in
Overweight Adults
The purpose of this study was to assess by randomized placebo-controlled trial the effect of 12
weeks of HIIT versus continuous aerobic exercise versus a sham-exercise placebo control on
body composition and cardiovascular risk factors in overweight, previously inactive adults.
Work capacity and body composition, via DEXA, were measured before and after 12 weeks of
intervention in 38 previously inactive overweight adults. For the exercise interventions, the HIIT
program consisted of repeated bursts of exercise on the cycle ergometer at a power output
designed to elicit 120% of VO2peak. Each exercise bout was interspersed with an active rest
period of cycling at a low intensity of 30 W. Intervals were progressed over the first four weeks
from 4 intervals on a work: recovery schedule of 30–45 sec at 120% of VO2peak: 2–3 min active
recovery. For weeks 5–12 participants performed 6 intervals on a work: recovery schedule of 60
sec exercise: 120 sec active recovery. The continuous endurance training program involved
continuous cycling on an ergometer. Training was began with 30 minutes at an intensity of 50%
of VO2peak in week one and progressively increased to 45 minutes at an intensity of 65% of
VO2peak by week 5 of the study. There was a significant group × time interaction for change in
work capacity, which increased significantly in the continuous endurance training by 23.8% and
in the HIIT group by 22.3% but not placebo group, which saw an increase of 3.1%. While there
was no significant main effect for percentage trunk fat, trunk fat reduced in the continuous
endurance training by 3.1% and in PLA by 1.1%, but not in HIIT, which increased 0.7%. There
was also a significant reduction in android fat percentage in continuous endurance training of
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2.7% and in the placebo group PLA of 1.4%, but again, not in the HIIT group where an increase
of 0.8% was observed. Due to the fact that this study observed no significant differences in
dietary intake and non-exercise physical activity, the changes in body composition are arguably
reflective of the effect of the interventions. These data suggest that HIIT may be advocated as a
time-efficient strategy for eliciting comparable fitness benefits to traditional continuous exercise
in inactive, overweight adults. However, in this population HIIT does not confer the same
benefit to body fat levels as continuous exercise training.
β-Hydroxy-β-Methylbutyrate Metabolism and Mechanisms
Nissen, Sharp, Paton, Vukovich, Trappe, Fuller Jr. (2000)
β-Hydroxy-β-Methylbutyrate (HMB) Supplementation in Humans Is Safe and May
Decrease Cardiovascular Risk Factors
The objective of this work was to present the collective safety data from nine studies in which
humans were fed 3 g HMB/d. The studies were from 3 to 8 wk in duration, the sample
populations of the studies included both males and females, young and old individuals, and
exercising or non-exercising populations. Organ and tissue function was assessed by blood
chemistry and hematology; subtle effects on emotional perception were measured with an
emotional profile test (Circumplex), and tolerance of HMB was assessed with a battery of 32
health-related questions. HMB did not adversely affect any surrogate marker of tissue health and
function. The emotion profile indicated that HMB significantly decreased one indicator of
negative mood, which translates into a more positive mindset. No negative effects of HMB were
indicated. Compared with the placebo, HMB supplementation resulted in a significant decrease
in total cholesterol of 5.8%, LDL cholesterol of 7.3% and systolic blood pressure (4.4 mm Hg, P
< 0.05). These effects of HMB on surrogate markers of cardiovascular health could result in a
decrease in the risk of heart attack and stroke. The only definitive effects of HMB were positive
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in nature, especially relating to lowering plasma cholesterol and blood pressure. In conclusion,
the objective data collected across nine experiments indicate that objective measures of health
and perception of well-being are generally enhanced after HMB consumption. Therefore, the
authors advise that HMB can be taken safely as an ergogenic aid for exercise and that the use of
supplementing 3 g/d of HMB as an ergogenic aid for exercise is well tolerated and safe in
humans.
Holecek, Muthny, Kovarik, Sispera (2009)
Effect of beta-hydroxy-beta-methylbutyrate (HMB) on protein metabolism in whole body
and in selected tissues
The aim of this study was to examine the effect of HMB administration on leucine and protein
metabolism in whole body and to estimate changes in protein synthesis and proteolysis in
selected tissues. Two tracers (L-[1-14C] leucine and L-[3,4,5-3H] phenylalanine) were used to test
the possible effect of interference of HMB and leucine metabolism and to avoid its effect on
interpretation of the obtained results. Male Wistar rats had a cannula inserted into the jugular
vein and a dose of 0.1 g/kg of body weight HMB was administered via the cannula for ½ of the
dose and the other ½ of the dose was given subcutaneously. The control group for this study
received saline administered in the same method. Whole-body protein metabolism were
evaluated 24 h later using L-[1-14C] leucine and L-[3,4,5-3H]phenylalanine. Changes in
proteasome dependent proteolysis and protein synthesis were determined according to the
‘‘chymotrypsin-like” enzyme activity as determined using the fluorogenic substrate Suc LLVYMCA and labeled leucine and phenylalanine incorporation into the protein. Amino acid
concentrations in de-proteinized samples of blood plasma or tissues were determined with
HPLC. A decrease in leucine clearance (control =1053 ± 36, HMB = 870 ± 52; p<0.05) and
whole-body protein turnover interpreted as a decrease in whole-body proteolysis (control =172 ±
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9, HMB = 144 ± 8; p<0.05) and protein synthesis (control =107 ± 8, HMB = 84 ± 5; p<0.05)
was discovered in HMB treated rats. Proteasome-dependent proteolysis decreased significantly
in skeletal muscle alone (control =6.9 ± 0.9, HMB = 3.8 ± 0.3; p<0.05), while changes in heart,
liver, jejunum, colon, kidney, and spleen were non-significant. Decreases in protein synthesis
were observed in the heart, colon, kidney, and spleen, while an increase was observed in the
liver. No significant changes in leucine oxidation were observed. The main effect of HMB
administration on protein metabolism seems to be the inhibition of proteasome dependent
proteolysis in skeletal muscle due to decreased levels of glutamate, glutamine and alanine in the
blood. The data also indicate that HMB is partly responsible for the inhibitory effect of
exogenous leucine on proteolysis and not for its stimulatory effect on protein synthesis. The
authors conclude that the protein anabolic effect of HMB in skeletal muscle is related to
inhibition of proteolysis in proteasome. Alterations in protein synthesis in visceral tissues may
affect several important functions and the metabolic status of the whole body.
Bruckbauer, Zemel, Thorpe, Akula, Stuckey, Osborne, Martin, Kennel, Wall (2012)
Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in
adipocytes and mice
The authors of this study sought to determine whether leucine would exhibit synergy with low
levels of resveratrol on sirtuin-dependent outcomes in adipocytes and in diet-induced obese
mice. One of the primary goals of the research was to investigate whether leucine and/or HMB
interact with resveratrol, a plant polyphenol found in the skin of red grapes and in other fruits to
act as another Sirt1 activator, in Silent Information Regulator Transcript 1(Sirt1) activation and
downstream effects. Sirt1 and Sirt3 stimulation leads to activation of mitochondrial biogenesis
and metabolism, resulting in increased fatty acid oxidation. To accomplish this, two studies
were performed, one in cell culture and then a second experiment extended to an in vivo mouse
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study where the downstream effects of Sirt1 activation were also measured. 3T3-L1 mouse preadipocyte cells were treated with leucine (0.5 mM), HMB (5 µM) or resveratrol (200 nM) alone
or in combination. In addition, diet-induced obese mice were treated for 6-weeks with low (2
g/kg diet) or high (10 g/kg diet) dose HMB, leucine (24 g/kg diet; 200% of normal level) or low
(12.5 mg/kg diet) or high (225 mg/kg diet) dose resveratrol, alone or as combination with
leucine-resveratrol or HMB-resveratrol. The combinations leucine-resveratrol or HMBresveratrol compared to the individual treatments significantly increased fatty acid oxidation,
AMPK, Sirt1 and Sirt3 activity in 3T3-L1 adipocytes and in muscle cells. Similarly, 6-week
feeding of low-dose resveratrol combined with either leucine or its metabolite HMB to dietinduced obese mice increased adipose Sirt1 activity, muscle glucose and palmitate uptake,
insulin sensitivity, improved inflammatory stress biomarkers (CRP, IL-6, MCP-1, adiponectin)
and reduced adiposity. The data from this study demonstrates that either leucine or its metabolite
HMB may be combined with a low concentration of resveratrol to exert synergistic effects on
Sirt1-dependent outcomes; this may result in more practical dosing of resveratrol in the
management of obesity, insulin-resistance and diabetes. Additionally, diet-induced obese mice
supplementing on HMB alone resulted in a significant change in insulin sensitivity and muscle
glucose uptake. Another novel finding of this study was that HMB, whether combined with
resveratrol or alone, resulted in a significant increase in AMPK activation and on the β–
activation in the adipocytes.
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Wilkinson, Hossain, Hill, Phillips, Crossland, Williams, Loughna, Churchward-Venne, Breen,
Phillips, Etheridge, Rathmacher, Smith, Szewczyk, Atherton
Effects of leucine and its metabolite β-hydroxy-β-methylbutyrate on human skeletal muscle
protein metabolism
This study aimed to investigate the possibility that HMB could represent an anabolic metabolite
of leucine by studying the effects of HMB on human muscle protein turnover and compared with
that of leucine. The authors carried the following three hypotheses into the experiment: 1) HMB
provision would acutely stimulate MPS; 2) HMB would stimulate muscle protein synthesis
through mechanisms similar to its precursor, leucine; 3) HMB would also acutely depress muscle
protein breakdown. Eight healthy young men, who were recreationally active but not involved in
a formal training program, were recruited for the study. On the morning of the study, subjects
had an 18 g cannula inserted into the antecubital vein of one arm for tracer infusion, a retrograde
14 g cannula inserted to sample arterialized blood from the dorsal capillary bed of the hand and –
in the HMB study only – had blood-sampling catheters inserted into the common femoral vein.
The researchers chose not to place the added burden of femoral lines on the subjects in the
leucine study due to the confounding factor of insulin secretion associated with leucine, since
studies using large doses of AAs have failed to show an effect on muscle protein breakdown
when insulin is clamped. A primed, continuous infusion of [1,2-13 C2] leucine tracer– and in the
HMB portion of the study [2H5] phenylalanine– was started (at t = −2.5 hr) after the first biopsy
and maintained until the end of the study (+2.5 hr). During the first 2.5 hr period baseline
measurements were gathered. The participants then ingested either 3.42 g of a buffered and
flavored free-acid HMB solution, which provided 2.42 g of HMB, or 3.42 g of L-leucine along
with ∼400 ml of water. Muscle biopsies (∼200 mg) were taken from the vastus lateralis, under
sterile conditions using a local anesthetic. Post-absorptive plasma glucose concentrations were
measured using an ILab 300 Plus Chemistry Analyser and plasma insulin concentrations were
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measured using undiluted samples on a high-sensitivity ELISA. Amino acid concentrations were
analyzed on a dedicated amino acid analyzer utilizing a lithium buffer separation. Plasma HMB
and amino acid concentrations were analyzed by gas chromatography–mass spectrometry.
Sarcoplasmic protein concentrations for determination of muscle protein synthesis were
evaluated via immunoblotting. Muscle protein breakdown was calculated via arterio-venous
dilution of the [2H5]-phenylalanine tracer. The results of the study indicated that orally
consumed free-acid HMB exhibited rapid bioavailability in plasma and muscle and stimulated
muscle protein synthesis—increase of 70%, similarly to 3.42 g leucine which increased muscle
protein synthesis by110%). While HMB and leucine both increased anabolic signaling via the
mTOR pathway, this was more pronounced with leucine. The phosphorylation of p70S6K1
increased similarly in both HMB (∼56%) and leucine (∼45%) groups at 30min. However, by
the 90 min time point increased p70S6K1 phosphorylation was maintained (∼71%) only in the
leucine group. HMB consumption also attenuated muscle protein breakdown decreasing
breakdown by 57% in an insulin-independent manner. The authors conclude that oral
consumption of HMB in free-acid form rapidly elevated plasma and intramuscular HMB
bioavailability from fasting concentrations and that exogenous HMB induces acute muscle
anabolism via increased muscle protein synthesis and reduced muscle protein breakdown
although there is still uncertainty if HMB acts separately or in conjunction with the
mechanism(s) of leucine.
Pinheiro, Gerlinger-Romero, es-Ferreira, de Souza-Jr, Vitzel, Nachbar, Nunes, Curi (2011)
Metabolic and functional effects of beta-hydroxy-beta- methylbutyrate (HMB)
supplementation in skeletal muscle
The aim of this study was to evaluate the effects of HMB supplementation for 4 weeks upon
metabolic parameters and skeletal muscle contractile function in rats. In the present study, the
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effects of HMB supplementation on ATP and glycogen content, citrate synthase activity,
maximum strength production, resistance to acute fatigue, contraction velocity and relaxation
capacity in skeletal muscle were investigated. Wistar rats were supplemented with 320 mg/kg of
body weight per day HMB for 4 weeks. A placebo group received the same volume of a saline
only solution. The animals were anesthetized and both hind limbs were fixed on an acrylic
platform. Direct electrical stimulation of the sciatic nerve was used to assess both tetanic force
and muscle twitch strength and resistance to acute muscle fatigue of the gastrocnemius muscle.
The gastrocnemius muscle was dissected into red and white portions, which were evaluated for
ATP and glycogen content via commercially available kits. The effect of HMB on citrate
synthase activity in the white and red portions of gastrocnemius muscle was determined by
spectrophotometer. No change in gastrocnemius muscle mass was observed in HMBsupplemented rats compared to placebo group. Muscle tetanic force was increased by HMB
supplementation. No change was observed in time to peak of contraction and relaxation time.
Resistance to acute muscle fatigue during intense contractile activity was also improved after
HMB supplementation. Glycogen content was increased fivefold in white and fourfold in red
portions of gastrocnemius muscle. HMB supplementation also doubled the ATP content in red
muscle cells and increased ATP concentrations in white portions of gastrocnemius muscle by
1.2-fold. Citrate synthase activity was increased by twofold in red portion of gastrocnemius
muscle. These results support the proposition that HMB supplementation results in metabolic
changes that are associated with increased muscle strength generation and prevention of acute
muscle fatigue via marked change in oxidative metabolism during intense contractions.
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Kimura, Cheng, Inoue, Hu, Koike, Kuzuya (2014)
β-Hydroxy-β-methylbutyrate facilitates PI3K/Akt-dependent mTOR and FoxO1/3a
phosphorylations and alleviates TNF-α/IFN-γ-induced MuRF-1 expression in C2C12 cells
In this study, researchers investigated the hypothesis that HMB may modulate the balance
between protein synthesis and degradation in the PI3K/Akt-mediated mammalian target of
rapamycin (mTOR) and FOXO1/FOXO3a-dependent mechanisms in differentiated C2C12
muscle cells. This study also tested the effect of HMB on the expression of MuRF-1 and
atrogin-1 in response to the inflammatory stress. C2C12 cells were cultured in serum-free
DMEM for 12 h, the cells were treated with 50 µM of HMB at time points: 0, 10, 30, and 60 min
and 24 h, for the Western blotting assay of targeted protein phosphorylations. Quantitative gene
expression was studied by using an ABI 7300 Real-Time PCR System. The protein
concentration for each sample was determined using a protein assay system and protein bands
were developed by the chemiluminescence method and detected using a digital imaging system.
HMB upregulated phosphorylation of Akt and mTOR beginning at the 10 min sample and
reached a 300% peak at 30 min, but had declined by the 60 min sampling point after the
intervention. Additionally, these effects were completely abolished in the presence of PI3K
inhibitor LY294002. Cells stimulated with HMB at 50 µM for 30 min upregulated FOXO1 and
FOXO3a phosphorylation. These changes were inhibited by LY294002, indicating that the
HMB-mediated FOXO1 and FOXO3a phosphorylations may be due to PI3K/Akt signaling
pathway activation. Kimura et al demonstrated that HMB failed to reduce the expressions of
atrophy-related atrogin-1 mRNA and the protein response to the pro-inflammatory cytokines
tumor Necrosis Factor-α (TNF-α) plus interferon-γ (IFN-γ). However, HMB did attenuate the
expression of the MuRF-1 gene. With respect to the effect of HMB on the prevention muscle
atrophy, Kimura and colleagues intimate that HMB appears to restore the balance between
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intracellular protein synthesis and proteolysis, likely via activation of the PI3K/Akt-dependent
mTOR and FoxO1/FoxO3 signaling pathway and the reduction of TNF-α/IFN-γ-induced MuRF1 expression. The findings of the present study suggest that HMB supplementation may be
beneficial for countering aging-related muscle wasting and muscle atrophy helping to limit
imbalance between protein synthesis and ubiquitin-proteasome-mediated proteolysis.
Fuller, Sharp, Angus, Baier, Rathmacher (2011)
Free acid gel form of β-hydroxy-β-methylbutyrate (HMB) improves HMB clearance from
plasma in human subjects compared with the calcium HMB salt
The present study was designed to examine whether HMB in free acid gel form could improve
HMB bioavailability to tissues over the previous Calcium salt form of HMB. To study this, the
researchers designed two longitudinal cross-over studies. In each study four males and four
females were given three treatments: 1) 1g CaHMB 2) equivalent HMB free acid gel swallowed
and 3) free acid gel held sublingual for 15 s then swallowed. For study 1, blood samples were
obtained at 2, 5, 10, 15, 25, 35, 45, 60, 90, 120 and 180 min after ingestion. In study 2,
additional blood samples were also obtained at 360, 720 and 1440 min after supplementation.
Plasma and urine HMB were analyzed by gas chromatography–mass spectrometry, while
portions of the pre-ingestion and 180 min blood samples (study 1) and samples from 1440 min
(study 2) were used for measurements of glucose, uric acid, blood urea nitrogen, creatinine, Na,
K, Cl, CO2, P, protein, albumin, globulin, albumin:globulin ratio, total bilirubin, direct bilirubin,
alkaline phosphatase, lactate dehydrogenase, aspartate aminotransferase, alanine
aminotransferase, g-glutamyl transpeptidase, Fe-binding capacity, unsaturated Fe-binding
capacity, Fe, Fe saturation, total cholesterol, TAG, HDL, LDL and cholesterol ratio were sent to
a commercial lab for analysis. Treatment with HMB did not result in differences in any of the
measured parameters for blood chemistry. Plasma HMB was measured for 3 h following
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treatment in study 1 and 24 h with urine collection in study 2. In both the studies, the time to
peak plasma HMB were significantly different between the forms of HMB, with 128min for the
calcium salt form of HMB, 38 min for HMB swallowed immediately and 38 min for HMB held
sublingually. Similarly, the authors also found a significant difference in the peak concentrations
between the different forms of HMB: 131 µmol/l for the calcium salt HMB, 249 µmol/l HMB
swallowed immediately and 239 µmol/l for HMB held sublingually. In addition, retention of
HMB was significantly higher in free acid form of HMB versus the calcium salt form as the
daily urinary HMB excretion was not significantly increased despite increases in plasma
concentration. Finally, the plasma half-life of HMB was significantly different between the
treatments of the two forms of HMB: 3.17hr for the calcium salt HMB , 2.50hr for HMB
swallowed and 2.51hr for HMB held sublingually. In summary, HMB delivery by free acid gel
results in a faster and greater peak in HMB plasma concentration as well as equally sustained
concentration compared with the calcium salt form of HMB administered in a capsule, is equally
safe and may improve HMB availability and efficacy to tissues in health and disease.
Effect of β-Hydroxy-β-Methylbutyrate Free Acid on Recovery
Wilson, Lowery, Joy, Walters, Baier, Fuller Jr, Stout, Norton, Sikorski, Wilson, Duncan, Zanchi,
Rathmacher (2012)
β-hydroxy-β-methylbutyrate free acid reduces markers of exercise-induced muscle damage
and improves recovery in resistance-trained men
The present study was designed to determine the effects of short-term supplementation with the
free acid form of HMB supplement administered just before a bout of resistance exercise on
indices of muscle damage, protein breakdown, recovery and hormone status resistance-trained
athletes. Twenty resistance-trained males were recruited to participate in a high-volume
resistance training session of three sets of twelve maximal repetitions intensity, with a supervised
and timed rest period length of 1min between the sets. The workout consisted of three sets of
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full squats, bench press, dead lifts, pull-ups, barbell bent over rows, parallel dips, military press,
barbell curls and triceps extensions. Participants were randomly assigned to receive either 3 g/d
of HMB or a placebo to be consumed divided equally in three servings: 30min before exercise,
with lunch and with an evening meal. Resting blood draws to evaluate serum creatine kinase,
urinary 3-methylhistadine, testosterone, and cortisol were obtained immediately before the
exercise session and 48 h post-exercise. Serum total testosterone, cortisol and C-reactive protein
were assayed via ELISA kits. Serum creatine kinase was measured using colorimetric
procedures at 340 nm. The results showed that creatine kinase increased 329% in the placebo
group, while the HMB group saw only a 104% increase above baseline. Participants also
reported a significant change for their perceived recovery status, in which responses decreased to
a greater extent in the placebo— 9.1 immediately prior to exercise and 4.6 48 hr post exercise—
than in the HMB group—9·1 immediately prior to exercise to 6·3 48 hr post exercise— meaning
the placebo group felt less recovered and more likely to do poorly is subsequent exercise.
Muscle protein breakdown, measured by 3-methylhistadine analysis, decreased 3.94% with
HMB supplementation and approached significance while no change was observed in the
placebo group. There were no reported changes in plasma total or free testosterone, cortisol or
C-reactive protein. In conclusion, these results suggest that an HMB supplement given to trained
individuals prior to intense exercise can blunt increases in muscle damage and may improve
perceived readiness for subsequent trainings following a high-volume, muscle-damaging
resistance-training session.
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Effect of Endurance Training and β-Hydroxy-β-Methylbutyrate Supplementation
Park, Henning, Grant, Lee, Lee, Arjmandi, Kim (2013)
HMB attenuates muscle loss during sustained energy deficit induced by calorie restriction
and endurance exercise
The purpose of this study was to investigate the efficacy and underlying mechanisms of HMB on
lean body mass, muscle mass and physical performance under normal training conditions with ad
libitum diet versus catabolic conditions induced by prolonged endurance exercise combined with
caloric restriction. The authors hypotheses were that HMB would enhance muscle mass and
physical performance under normal training conditions and would help to attenuate the loss of
muscle mass and physical performance under catabolic conditions. For this study, 61 six-week
old C57BL/6 male mice were divided into three baseline groups: 1) TB = true baseline, sedentary
control (n = 7); 2) B = baseline (n = 27); and 3) BH = baseline + HMB (0.5 g/kg BW/d) (n = 27).
Groups B and BH underwent a four-week run-in phase to simulate initial entry training that
soldiers go through upon entering the military where mice exercised three days a week for one
hour each day at a speed of 6 m/min (i.e. fast walk) on a forced exercise wheel. After this initial
period, 7 mice from each group were removed from the study and utilized for baseline measures.
The 20 remaining mice from the B group were then randomly assigned into ALT [= ad libitumtrained (exercised 1 h/d for 3 d/wk, 6 m/min)] and C [= caloric restricted (−30% of ad libitum
groups) + trained (~6 h/d = 2 km/d, 6 d/wk, 6 m/min speed)] groups. The 20 remaining mice
from the BH group were randomly assigned into ALTH [= ad libitum-trained + HMB (0.5 g/kg
BW/d)] and CH (= C + HMB groups) (n = 10/group). The second portion of the training
experiment lasted 6 weeks. Repeated in vivo assessments included body composition via
DEXA, grip strength and sensorimotor coordination and were performed after the initial 4 week
initiation portion and after the 6 week experimental protocol. In vitro analyses included muscle
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wet weights, expression of selected genes and proteins regulating muscle mass, and myofiber
cross-sectional area. There was no significant difference pre to post between the ALT and
ALTH groups for total body mass. Both of the groups that were fed an ad libitum diet increased
in weight over the course of the 6 week training period. However, the ALTH group had 17%
greater lean body mass than ALT after the training period. Conversely, in the catabolic groups,
the group without HMB, C group, had 17% greater lean body mass than the HMB supplemented
group, CH, after the experimental protocol. Fat mass increased 25% in ALT, this created a 12%,
significant difference between the ALT and ALTH groups after the training protocol. Both
catabolic groups had significantly lower fat mass than the normal training groups after the
training protocol. Interestingly, fat mass decreased by 56% in the C group, but only 38% in the
CH after the training period. The only group where a decrease in grip strength occurred was
group C, where a 10% decrease was observed. Grip strength was maintained in CH and
following the protocol, group CH had an 11% greater grip strength than the C group.
Gastrocnemius mass was significantly greater (+10%) in CH than C following catabolic
conditions. Similarly, the mean cross-sectional area of C was 35% lower compared to CH after
the experimental protocol. Therefore, the group supplementing HMB, CH, significantly
attenuated the decrease in fiber cross-sectional area of the gastrocnemius. Finally, gastrocnemius
atrogin-1 mRNA expression was elevated in C but not in CH compared to all other groups.
Atrogin-1 protein levels, however, showed no significant changes. In conclusion, the major
findings reported by the authors are that HMB intake during a catabolic condition attenuates loss
of strength, muscle mass and myofiber cross-sectional area, but not lean mass as measured via
DEXA. It is also relevant that HMB increased lean body mass, attenuated increases in fat mass
and improved sensorimotor function under normal training conditions.

	
  

32	
  

Knitter, Panton, Rathmacher, Petersen, Sharp (2000)
Effects of β-hydroxy-β-methylbutyrate on muscle damage after a prolonged run
This study examined the effects of supplementing HMB on muscle damage as a result of an
acute bout of intense continuous endurance exercise. All participants involved in this study
regularly partook of endurance training, only subjects running at least 48 km/wk were selected to
participate. Participants, 8 males and 8 females, were paired according to their 2-mile run times
and past running experience. Each pair was randomly assigned a treatment of either HMB (3
g/day) or a placebo. Participants supplemented three times a day at meal times for 6 weeks prior
to the run, and for 4 days after the run. Daily training was allowed to occur ad libitum. All
participants then took part in an acute bout of continuous endurance exercise in the form of a 20
km run. Blood samples were taken prior to supplementation, 4 weeks after supplementation
began, immediately after completion of the prolonged run, and every day for 4 days after the
prolonged run. Serum samples were analyzed for creatine phosphokinase and lactate
dehydrogenase activity by a commercial laboratory. Plasma was collected and analyzed for
HMB by gas chromatography-mass spectrometry. The placebo-supplemented group exhibited a
significantly greater increase in creatine phosphokinase activity in the 4-day period after
prolonged run than did the HMB-supplemented group (Day 1=37%, Day 2=39%, Day 3=38.5%,
Day 4=11.3%). Additionally, when covaried for pre-run values, LDH activity was significantly
lower with HMB supplementation compared with the placebo-supplemented group. In
conclusion, the authors suggest that the fact that the placebo-supplemented subjects exhibited
higher lactate dehydrogenase activity after the prolonged run compared with the HMBsupplemented subjects suggests that they would tend to sustain more muscle damage as a result
of the run. This fact combined with the lower Creatine phosphokinase levels of the HMB
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supplementing group support the authors’ hypothesis that HMB supplementation helps prevent
exercise-induced muscle damage.
Vukovich, Dreifort (2001)
Effect of [beta]-Hydroxy [beta]-Methylbutyrate on the Onset of Blood Lactate
Accumulation and Vo2peak in Endurance-Trained Cyclists
The purposes of this study were to: 1) investigate the effects of HMB supplementation on the
onset of blood lactate accumulation and VO2peak and in endurance- trained cyclists, both
indicators of training status; 2) examine the effect of acute exercise on plasma HMB
concentrations. Eight male master-level competitive cyclists participated in the study. Training
volume of the subjects was ~280–330 miles per week. The training was allowed to proceed ad
libitum and consisted of intervals (aerobic and anaerobic), sprints, and racing. Participants were
randomly assigned to complete three 2-week supplementation periods (HMB, leucine, or
placebo) each followed by a 2-week washout period. The study utilized cross-over design, so
subjects acted as their own controls. For the VO2peak and time to reach VO2peak test
participants cycled at a rate of 90 rpm at 150 W. Wattage was increased by 25 W every 3
minutes until the subject could no longer maintain 80 rpm. The fractional concentrations of
oxygen and carbon dioxide in the expired air were analyzed with a Quinton Q-Plex 1 metabolic
cart. Researchers collected blood samples during the last 20 seconds of each stage from a
catheter inserted into a forearm vein for determination of blood lactate, plasma glucose, HMB,
and free fatty acids. Immediately after the completion of the test a blood sample was obtained
for the determination of blood lactate concentration associated with VO2peak. The
supplementation protocol consisted of 3 g of cornstarch·day-1 (CON), 3 g of Ca-HMB· day-1, and
3 g of leucine· day-1 (LEU). Capsules were identical in size and appearance and participants
were instructed to consume 4 capsules 3 times per day for a total of 12 capsules per day. A 1-
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way RMANOVA on relative changes in VO2peak and time to reach VO2peak resulted in a
significant increase of 4% in VO2peak and 3.5% in time to reach VO2peak during the HMB trial,
which was greater than the leucine or placebo trials. Two-way RMANOVA resulted in a
significant time and treatment effect. The onset of blood lactate accumulation was significantly
higher after HMB (9.1% increase pre to post) supplementation compared with both the placebo
(0.75%) and leucine (2.1%) trials. The relative increase in VO2 at 2 mM blood lactate, as
analyzed by a one-way RMANOVA, was also significantly greater after HMB (8.6% increase
pre to post) supplementation compared with leucine (4.2%) or placebo (2.1%) trials. Although
the results of the current study lend support the hypothesis that HMB supplementation may have
positive effects on aerobic performance by delaying the onset of blood lactate accumulation, the
authors caution that they believe no adaptations occurred. Vukovich and Dreifort do offer up a
further hypothesis that if HMB prevents protein breakdown and increases protein synthesis, then
cellular and mitochondrial proteins may increase. This may result in a greater oxidative system
in which electrons from NADH, formed within the cytosol, are shuttled into the mitochondria
allowing for increased oxidative phosphorylation, rather than producing lactate through the
reduction of pyruvate.
Lamboley, Royer, Dionne (2007)
Effects of beta-hydroxy-beta-methylbutyrate on aerobic-performance components and
body composition in college students
The aim of this study was to determine the effects of the calcium salt form of HMB
supplementation coupled with a 5-week interval-training program, in active college students
unaccustomed to this kind of training, on selected components of aerobic performance and body
composition. Eight men and eight women were randomly assigned to either an HMB or a
placebo group for a 5-wk supplementation period during which they underwent interval training
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3 times a week on a treadmill. Body composition, including measurements of total body mass,
as well as body fat and lean body mass, was determined using DEXA. An incremental
continuous test to exhaustion on a treadmill was performed using a breath-by-breath gas
analyzer. Researchers collected respiratory gases to measure VO2max, as well as ventilatory
threshold and respiratory compensation point. Ventilatory threshold was determined to be the
intensity corresponding to an increase in VE:VO2 without a simultaneous increase of VE:VCO2,
the first sustained rise in excess CO2, and the first increase in the slope of VCO2 versus VO2.
The authors measured the respiratory compensation point as the intensity corresponding to an
increase in both VE:VO2 and VE:VCO2, the second sustained rise in excess CO2, and the second
increase in the slope of VCO2 versus VO2. Participants were next tested to measure the time to
exhaustion at the maximal aerobic speed—defined as the lowest speed that elicited VO2max
during the graded exercise test. Training consisted of a 5-wk training program utilizing interval
training on a treadmill 3 times a week. An interval-training cycle consisted of 5 exercise bouts
with each bout equal to 100% of an individual’s total time as measured by the time to exhaustion
test. Therefore, for an individual workout, an individual began with a warm-up period of 5 min
at 50% of the maximal aerobic speed. After this warm-up, an initial active recovery of running
began at an intensity equivalent to 60% of maximal aerobic speed followed immediately by a
fast run at an intensity equivalent to 100% of maximal aerobic speed. Therefore, the slow run
and fast run of each interval-training cycle were each the same duration: 50% of the total time to
exhaustion. VO2max for both groups significantly increased after the exercise intervention.
However, when the investigators expressed this as a percentage of increase, it indicated that
VO2max increased significantly more in the HMB group (15.5%) than in the placebo group
(8.4%). The researchers found no significant difference in any measure of body-composition
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data between the pre- and posttest for either studied group. Furthermore, they discovered no
significant difference between the 2 groups for all body-composition variables after the training
and supplementation period. Although the time to exhaustion decreased significantly in both
groups, the authors found that again, the HMB supplemented group (-42.4%) was significantly
different from the placebo group (-27.1%). Further, the researchers discovered that ventilatory
threshold was improved significantly in both groups, with no significant difference between the
two supplemental interventions. Similarly, there was a significant increase in respiratory
compensation point for both of the interventions. However, as with the VO2max, when
expressed as a percentage of VO2max, respiratory compensation point significantly improved
more for the HMB group (13.4%) than for the PLA group (8.4%). The authors concluded that
although the mechanisms whereby HMB influences some components of sport performance are
unknown supplementation with HMB coupled with a high-intensity interval training program
induced a greater increase in VO2max and in respiratory compensation point in active subjects
thereby positively affecting selected components of aerobic performance in active college
students.
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CHAPTER III
Participants
For inclusion in the study, all males were required to have a 𝑉O2peak greater than 35
ml·kg-1·min-1 and all female participants greater than 30 ml·kg-1·min-1. After initial testing, forty
recreationally active individuals (Men = 21, Women = 19) between the ages of 18 and 35 were
recruited to participate in this study. Three female and two male participants were removed due
to health reasons not associated with the study. One female participant was removed after a
family emergency. Therefore, data for 19 men and 15 women (Table 1) were included in the
final analysis. All participants completed a questionnaire to assess ability to participant in
physical activity and to ascertain any prior supplementation regime. Individuals were selfreported to be free of musculoskeletal injury as determined by a PAR-Q. All persons
participating in this study were provided an informed consent to sign and the New England
Institutional Review Board approved the study protocol.

Variable
Age (y)
Height (cm)
Body Mass (kg)
% Body Fat
Training Volume (kJ)

Table 1. Participant Descriptive Data (N=34)
HIIT
HMB-HIIT
Control
(n=13:M=8;
(n=13;M=7;
(n=8:
F=5)
F=6)
M=5;F=3)
21±2.39
23.62±3.73
22.85±2.44
171.43±5.72 172.57±12.21
173±9.22
76.29±12.76
74.92±16.59
72.38±9.87
22.36±8.12
19.68±8.64
24.83±8.09
N/A
1436.98±309.6
1456.75±378.55

F
1.907
0.063
0.234
1.250
1.06

p
0.166
0.939
0.793
0.301
0.313

A minimum sample size of n=8 per group was determined using previously published
data (Lamboley et al., 2007) and the formula derived by Gravettier and Wallnau (1996) to
achieve a statistical power (1-β) of 0.80. Therefore, with an expectation of subject dropout, a
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final sample size of n=15 in each experimental group and n= 10 in the control group were
recruited. The study was registered on ClinicalTrials.gov (ID NCT01941368).
Research Design
A double blind, placebo controlled design, stratified for gender, was used to examine the
effects of HMB and HIIT training on measures of metabolic performance. Each participant was
required to visit the Human Performance Laboratory four times for pre- and post- testing, with
each testing session occurring on nonconsecutive days. The same testing protocols were repeated
at the end of the 4-week training period. On the first testing day, anthropometric measures of
participants were collected (Table 1). Each participant then performed a graded exercise test to
determine peak oxygen consumption (𝑉O2peak), time to exhaustion (Tmax), respiratory
compensation point (RCP), and ventilatory threshold (VT). The peak wattage achieved during
this testwas used to establish individual training intensity. On the second day of testing, a
baseline blood draw was performed to measure serum HMB, and total lean soft tissue (TLST)
and body fat percentage (BF) were assessed using dual energy x-ray absorptiometry (DEXA)
(ProdigyTM; Lunar Corporation, Madison, WI, USA).
After baseline testing, the participants were randomly assigned to one of three groups: a
control group (CTL), a placebo+HIIT group (HIIT) or HMB+HIIT group (HMB-HIIT). Of the
40 subjects that were recruited for this study, 10 subjects were assigned to CTL and 15 to each of
the training groups (HIIT or HMB-HIIT). In addition, participants were stratified for gender for
each group.
Exercise Protocol
Participants in the HIIT and HMB-HIIT groups participated in 4-weeks of high-intensity interval
training with three sessions per week—with at least one day between each training session—on
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calibrated, electronically-braked cycle ergometer (Corival 400, Groningen, the Netherlands).
The exercise training regime consisted of alternating training sessions of sub maximal and supra
maximal workloads (Figure 1). Each participant’s training load was determined as a percentage
of the peak power output (Ppeak) from the graded exercise test. Individuals began each training
session with a 5-minute warm up at a self-selected wattage, followed by a protocol of five 2minute exercise bouts at a predetermined percentage of their power output at 𝑉O2peak. Between
each exercise bout, the participant had 1 minute of complete rest. Persons assigned to CTL were
asked to continue their normal activity pattern for 4 weeks before returning to undergo posttesting.
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Figure 1. Exercise training intensity protocol
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Supplementation
The HMB supplement consisted of 1 gram of β-hydroxy-β-methylbutyrate free acid, reverse
osmosis water, de-bittering agent, orange flavor, stevia extract, and potassium carbonate. Each
serving of placebo contained 1 gram of polydextrose that was equivalent to β-hydroxy-βmethylbutyrate free acid, citric acid, corn syrup, 10% stevia powder, de-bittering agent, and
orange flavoring. The HMB and the placebo were obtained from Metabolic Technologies Inc.
(Ames, IA). Prior to the exercise session, subjects were randomly assigned to receive either 3 g
per day of HMB or a placebo divided equally into three servings given 30 minutes prior to
exercise and again 1 hour later and then final 1g dose 3 hours post exercise. To ensure
compliance, investigators watched as the subjects consumed the supplement prior to and
immediately after each exercise session. On the non-training days, subjects were instructed to
consume one packet with three separate meals throughout the day. Empty packets were
presented to the investigators upon returning to the laboratory following non-training days. In
addition, blood plasma HMB concentrations were analyzed by gas chromatography-mass
spectrometry which was performed by Metabolic Technologies Inc. in a blinded fashion using
methods previously described by Nissen et al. 1990.
Dietary Analysis
Prior to training, participants were asked to complete a 3-day food log, to establish macronutrient
content and average leucine intake. This diet was considered his or her standard diet and he or
she was asked to replicate this style of diet throughout the study. These data were entered into a
software program (Food Works 13, The Nutrition Company, Long Valley, NJ) which provided
calculation for daily leucine intake (g) and total calories (kcal).
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Metabolic and Performance Measures
The independent variables included: (a) supplementation treatment [HMB vs. placebo], (b)
exercise treatment [HIIT training vs. control]. The dependent variables included: (a) 𝑉O2peak,
(b) Tmax, (c) RCP, (d) VT, (e) TLST, and (f) BF.
Instrumentation
•

An electronically-braked cycle ergometer (Lode Excalibur Sport, Groningen, the
Netherlands) was utilized to perform all graded exercise tests.

•

An electronically-braked cycle ergometer (Corival 400, Groningen, The Netherlands)
was used for training sessions.

•

Open circuit spirometry (True One Metabolic Cart, Parvo Medics, Inc., Sandy UT) was
used in the determination of all metabolic measures.

•

DEXA (GE Medical Systems Lunar, Madison, WI, USA; software version 13.60.033)
was used to determine body composition.
Determination of VO2peak, VT, and RCP
An incremental test to volitional exhaustion was performed on an electronically-braked

cycle ergometer (Lode Excalibur Sport, Groningen, The Netherlands) to determine 𝑉O2peak and
the peak power output (Ppeak) in watts (W) at 𝑉O2peak. Prior to testing, each participant was
fitted with a Polar Heart Watch system to record his or her heart rate (Polar Electro Inc., Lake
Success, NY). Following the procedures described by Bergstrom et al. (2013), participants were
instructed to maintain a pedaling cadence of 70-75 revolutions per minute (RPM) at an initial
workload of 75 W. The workload increased 25 W every two minutes until he or she was unable
to maintain a cadence above 70 RPM for ~10s despite verbal encouragement, or volitional
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fatigue. Prior to each graded exercise test, open-circuit spirometry (True One Metabolic Cart,
Parvo Medics, Inc., Sandy UT) was calibrated with room air and gases of known concentration,
which was used to estimate 𝑉O2peak (ml·kg-1·min-1) by sampling and analyzing the breath-bybreath expired gases. Respiratory gases—oxygen (O2), carbon dioxide (CO2), ventilation (𝑉 E),
and respiratory exchange ratio (RER)—were monitored continuously and expressed as 30second averages (Day et al., 2003). 𝑉O2peak was determined to be the highest 30-s 𝑉O2 value
during the test and coincided with at least two of the following three criteria: (a) 90% of agepredicted maximum heart rate; (b) respiratory exchange ratio > 1.1; and/or (c) a plateau of
oxygen uptake (less than 150mL/min increase in 𝑉O2 during the last 60 s of the test). The testretest reliability for 𝑉O2peak was ICC= 0.86 (SEM 2.2 ml.kg.min-1).
Ventilatory threshold (VT), and respiratory compensation point (RCP), were determined
by common methods for determining gas exchange thresholds (Beaver et al. 1986, Gaskill et al.
2001, Wasserman et al. 1973, Caiozzo et al. 1982) Ventilatory threshold (VT), was determined
by plotting and determining the point of increase in the 𝑉 E/𝑉O2 versus 𝑉O2 curve as the
𝑉 E/𝑉CO2 versus 𝑉O2 curve remained constant or decreased (Bergstrom et al. 2013, Beaver,
Wasserman & Whipp, 1986). The respiratory compensation point (RCP), as described by
Beaver et al. (1986), was identified using the V-Slope method by plotting the 𝑉 E versus 𝑉CO2.
The VT and RCP were reported as the corresponding 𝑉O2 and power output in watts (pVT and
pRCP). The test-retest reliability for  VT and PVT was ICC= 0.86 (SEM 3.6 ml.kg.min-1) and
0.77 (SEM 16.1 watts), respectively.
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Anthropometric Measures
Body composition was estimated from a scan by DEXA (GE Medical Systems Lunar,
Madison, WI, USA; software version 13.60.033) performed by a state licensed x-ray technician.
Participants were positioned supine in the center of the platform and were scanned using the
default scan mode for total body scanning. Measures for lean soft tissue and fat mass for limb,
regional, and total body were calculated by the system software (Encore 2011, software version
13.60.033). Body composition was analyzed using estimated body fat percentage (BF) and total
body lean mass (LM). The test-retest reliability for BF was ICC= 0.99 (SEM 0.8 %Fat).
Statistical Analysis
Statistical software (IBM SPSS Statistics for Windows, Version 21.0. Armonk, NY: IBM
Corp) was used to perform all statistical analysis. Separate 1-way analyses of covariance
(ANCOVA) were used to analyze all dependent variable data based on the recommendations of
Huck and McLean (1975). The independent variable, group, included 3 levels: HIIT, HMBHIIT, and CTL. The pretest and posttest values were used as the covariate and dependent
variable, respectively. Preliminary least squares regression analyses were conducted to examine
the linearity of the relationships between the covariate and the dependent variable within all
groups, and the interaction between the covariate and group was used to test for homogeneity of
slopes (Green, Salkind, & Akey, 2000). When appropriate, LSD post hoc pairwise comparisons
were used to examine the differences among the groups. For effect size, the partial eta squared
(Green et al. 2000) statistic was calculated, and according to Green et al. (2000), 0.01, 0.06, and
0.14 represents small, medium, and large effect sizes, respectively. An alpha of p<0.05 was
established a priori.
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CHAPTER IV
Results
The pre- and post-intervention mean and standard deviations for all metabolic and
performance measures (𝑉O2peak, Ppeak, Tmax, RCP, PRCP, VT, and PVT) for all groups (CTL,
HIIT, HMB-HIIT) are provided in Table 2. Table 3 provides the group mean and standard
deviations for pre- to post-intervention body composition measures (BW, LSTM, total body fat
mass, and BF).
Peak Oxygen Uptake (VO2peak)
The ANCOVA indicated a significant difference (p=0.003, η2=0.322) among the group
means for the posttest 𝑉O2peak  values after adjusting for pre-test differences (Figure 2). The
strength of the association (i.e., effect size, η2) indicated that the treatment groups (CTL, HIIT,
HMB-HIIT) accounted for 32% of the variance of the posttest 𝑉O2peak  values, holding constant
the pretest VO2peak  scores. The LSD pairwise comparisons indicated that the increase in
𝑉O2peak from pretest to post-testing was greater for the HMB-HIIT group than for the CTL
(p=0.001) and the HIIT groups (p=0.032), however, no differences were found between HIIT
and CTL groups (p=0.09). The group means (±SEM) for the posttest VO2peak values, adjusted
for initial differences in pretest scores, are shown in Figure 2.
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Table 2. Metabolic and Performance Measures for Pre- and Post-Supplementation
Measure
VO2peak (mL·kg–1·min–1)
Ppeak (W)
Tmax (min)
–1

–1

RCP (mL·kg ·min )
PRCP (W)
–1

–1

VT (mL·kg ·min )

Control (n=8)
Pretest
Posttest
39.1±4.5
38.9±4.0

HIIT (n=13)
Pretest
Posttest
38.9±3.4
40.3±2.6

HMB-HIIT (n=13)
Pretest
Posttest
39.8±6.7
42.7±5.1

218.75±41.7

215.63±32.6

221.15±46.6

236.54±48.5

226.92±56.3

246.15±54.8

12.5±2.9

12.2±2.3

13.0±3.8

14.2±3.7

13.6±4.7

14.9±4.5

30.49±5.0

28.71±2.7

29.33±3.1

31.88±2.2

32.16±4.2

33.73±3.8

175.25±38.8

167±24.8

168.35±36.0

184.96±33.5

182.62±33.6

196.5±35.1

30.15±5.01

29.23±4.5

28.63±3.1

29.04±4.1

27.84±4.8

31.66±3.7

PVT (W)
156.25±17.7
153.13±28.2
159.6±40.2
169.2±37.0
161.54±39.02
184.62±37.6
Values are means±SD. HIIT, high intensity interval training; HMB, β-hydroxy-β-methylbutyrate; VO2peak, peak oxygen uptake; Ppeak,
peak power achieved; Tmax, time to exhaustion during graded exercise test; RCP, respiratory-compensation point;
VT, ventilatory threshold;

Table 3. Body Composition Measures for Pre- and Post-Supplementation
Measure
Body Weight (kg)
Lean Soft Tissue Mass
(kg)
Total Body Fat Mass
(kg)
Body Fat %

Control (n=8)
Pretest
Posttest

HIIT (n=13)
Pretest
Posttest

HMB-HIIT (n=13)
Pretest
Posttest

76.3±12.8

75.5±12.7

74.9±16.6

75.2±16.3

72.4±9.9

72.5±10.0

56.5±11.7

56.4±10.7

58.4±16.6

58.6±16.6

52.2±10.9

52.2±10.9

15.9±7.0

14.3±8.4

13.3±4.8

13.2±4.6

16.9±5.3

17.0±5.4

22.4±8.1

22.0±2.8

19.7±8.6

19.5±8.4

24.8±8.1

24.6±7.7

Values are means +SD. HIIT, high intensity interval training; HMB, β-hydroxy-β-methylbutyrate.
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Figure 2. 𝑽O2peak obtained during graded exercise test. Mean values (+SEM) for posttest
𝑽O2peak scores adjusted for the initial differences in pretest VO2peak (covariate; adjusted pretest
mean=39.3). *HMB significantly greater than HIIT (p=0.032) and CTL (p=0.001)

Peak Power (Ppeak)
The ANCOVA indicated a significant difference (p=0.013, η2=0.251) among the group
means for the posttest Ppeak values after adjusting for pre-test differences (Figure 3). The
strength of the association (i.e., effect size, η2) indicated that the treatment groups (CTL, HIIT,
HMB-HIIT) accounted for 25% of the variance of the posttest Ppeak values, holding constant the
pretest Ppeak scores. The LSD pairwise comparisons indicated that the increase in Ppeak from
pretest to post-testing was greater for the HMB-HIIT (p=0.04) and HIIT (p=0.018) groups than
for the CTL group, however, no differences were found between HMB-HIIT and HIIT groups
(p=0.51). The group means (±SEM) for the posttest Ppeak values, adjusted for initial differences
in pretest scores, are shown in Figure 3.
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Figure 3. Peak power (Ppeak) obtained during graded exercise test. Mean values (+SEM) for
posttest Ppeak scores adjusted for the initial differences in pretest Ppeak (covariate; adjusted pretest
mean=222.79). *Indicates significantly different than CTL (HIIT, p=0.018; HMB-HIIT, p=0.04)
Time to Exhaustion (Tmax)
The ANCOVA indicated a significant difference (p=0.002, η2=0.35) among the group
means for the posttest Tmax values after adjusting for pre-test differences (Figure 4). The strength
of the association (i.e., effect size, η2) indicated that the treatment groups (CTL, HIIT, HMBHIIT) accounted for 35% of the variance of the posttest Tmax values, holding constant the pretest
Tmax scores. The LSD pairwise comparisons indicated that the increase in Tmax from pretest to
post-testing was greater for the HMB-HIIT (p=0.001) and HIIT (p=0.002) groups than for the
CTL group, however, no differences were found between HMB-HIIT and HIIT groups (p=0.62).
The group means (±SEM) for the posttest Tmax values, adjusted for initial differences in pretest
scores, are shown in Figure 4.
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Figure 4. Time to exhaustion (Tmax) for the graded exercise test. Mean values (+SEM) for
posttest Tmax scores adjusted for the initial differences in pretest Tmax (covariate; adjusted pretest
mean=13.11). *Indicates significantly different than CTL (HIIT, p=0.002; HMB-HIIT, p=0.001)
Respiratory Compensation Point (RCP)
The ANCOVA indicated a significant difference (p<0.001, η2=0.436) among the group
means for the posttest RCP values after adjusting for pre-test differences (Figure 5). The
strength of the association (i.e., effect size, η2) indicated that the treatment groups (CTL, HIIT,
HMB-HIIT) accounted for 44% of the variance of the posttest RCP values, holding constant the
pretest RCP scores. The LSD pairwise comparisons indicated that the increase in RCP from
pretest to post-testing was greater for the HMB-HIIT (p<0.001) and HIIT (p<0.001) groups than
for the CTL group, however, no differences were found between HMB-HIIT and HIIT groups
(p=0.77). The group means (±SEM) for the posttest RCP values, adjusted for initial differences
in pretest scores, are shown in Figure 5.
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Figure 5. Respiratory compensation point (RCP). Mean values (+SEM) for posttest RCP scores
adjusted for the initial differences in pretest RCP (covariate; adjusted pretest mean=30.69).
*Indicates significantly different than CTL (HIIT, p<0.001; HMB-HIIT, p<0.001)

Power at Respiratory Compensation Point (PRCP)
The ANCOVA indicated a significant difference (p=0.001, η2=0.375) among the group
means for the posttest PRCP values after adjusting for pre-test differences (Table 2, Figure 6).
The strength of the association (i.e., effect size, η2) indicated that the treatment groups (CTL,
HIIT, HMB-HIIT) accounted for 38% of the variance of the posttest PRCP values, holding
constant the pretest PRCP scores. The LSD pairwise comparisons indicated that the increase in
PRCP from pretest to post-testing was greater for the HMB-HIIT (p<0.001) and HIIT (p<0.001)
groups than for the CTL group, however, no differences were found between HMB-HIIT and
HIIT groups (p=0.97). The group means (±SEM) for the posttest PRCP values, adjusted for
initial differences in pretest scores, are shown in Figure 6.
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Figure 6. Power at respiratory compensation point (PRCP). Mean values (+SEM) for posttest
PRCP scores adjusted for the initial differences in pretest PRCP (covariate; adjusted pretest
mean=175.43). *Indicates significantly different than CTL (HIIT, p=0.001; HMB-HIIT,
p=0.001)

Ventilatory Threshold (VT)
The ANCOVA indicated a significant difference (p=0.016, η2=0.24) among the group means for
the posttest VT values after adjusting for pre-test differences (Figure 7). The strength of the
association (i.e., effect size, η2) indicated that the treatment groups (CTL, HIIT, HMB-HIIT)
accounted for 24% of the variance of the posttest VT values, holding constant the pretest VT
scores. The LSD pairwise comparisons indicated that the increase in VT from pretest to posttesting was greater for the HMB-HIIT group than for the CTL (p=0.012) and the HIIT groups
(p=0.017), however, no differences were found between HIIT and CTL groups (p=0.6). The
group means (±SEM) for the posttest VT values, adjusted for initial differences in pretest scores,
are shown in Figure 7.
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Figure 7. Ventilatory Threshold (VT). Mean values (+SEM) for posttest VT scores adjusted for
the initial differences in pretest VT (covariate; adjusted pretest mean=28.68). *HMB-HIIT
significantly greater than HIIT (p=0.017) and CTL (p=0.012)
Power at Ventilatory Threshold (PVT)
The ANCOVA indicated a significant difference (p=0.009, η2=0.267) among the group means
for the posttest PVT values after adjusting for pre-test differences (Figure 8). The strength of the
association (i.e., effect size, η2) indicated that the treatment groups (CTL, HIIT, HMB-HIIT)
accounted for 27% of the variance of the posttest PVT values, holding constant the pretest PVT
scores. The LSD pairwise comparisons indicated that the increase in PVT from pretest to posttesting was greater for the HMB-HIIT group than for the CTL (p=0.004) and the HIIT groups
(p=0.027), however, no differences were found between HIIT and CTL groups (p=0.277). The
group means (±SEM) for the posttest PVT values, adjusted for initial differences in pretest
scores, are shown in Figure 8.

	
  

52	
  

200	
  

	
  	
  	
  	
  *	
  

190	
  
180	
  

PVT (W)

170	
  
160	
  
150	
  
140	
  
130	
  
120	
  
110	
  
100	
  
CTL	
  

HIIT	
  

HMB-‐HIIT	
  

Figure 8. Power at ventilatory threshold (PVT). Mean values (+SEM) for posttest PVT scores
adjusted for the initial differences in pretest PVT (covariate; adjusted pretest mean=160.29).
*HMB significantly greater than HIIT (p=0.027) and CTL (p=0.004)
Body Composition
The ANCOVA indicated no significant difference for body mass (p=0.31, η2=0.074)
percent body fat (p=0.88, η2=0.009), and lean soft tissue mass (p=0.247, η2=0.089) between the
all groups (Table 3).
Training Volume
An independent-samples t-test was performed to compare total training volume for the
HIIT and HMB-HIIT groups. There was no significant difference (p=0.31) between training
volumes for HIIT (1436.98±309.6 kJ) and HMB-HIIT (1456.75±378.55 kJ).
Dietary Analysis
An independent-samples t-test was performed to compare the dietary intake of total
energy intake and the amount of the amino acid, leucine, consumed for the HIIT and HMB-HIIT
groups. There was no significant difference for energy intake (p=0.159;HIIT,
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2398.65±619.5Kcal; HMB-HIIT, 2011±620.2Kcal) or leucine intake (p=0.561;HIIT,
3.32±1.74g; HMB-HIIT, 3.85±2.13g) between the two treatment groups.
Supplementation Compliance
Placebo or HMB intake was recorded on individual intake logs, which were returned to
the laboratory and monitored and resulted in 99% compliance. In addition, blood plasma HMB
concentrations were analyzed by gas chromatography-mass spectrometry and performed by
Metabolic Technologies Inc. using methods previously described to assess compliance and
validate HMB in supplement packets (Nissen et al., 1990). HMB levels significantly (p=0.043)
increased in the HMB-HIIT group (2.49±2.97 nmol·ml-1) with no change (p=0.68) in the HIIT
group (-0.08±0.21 nmol·ml-1).
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CHAPTER V
Discussion
To the best of our knowledge, this is the first study to examine the effects of the freeacid form of β-hydroxy-β-methylbutyrate (HMB) supplementation and cycling high-intensity
interval training (HIIT) on metabolic and performance measures in young men and women. The
primary findings support the use of HIIT as a training method to improve aerobic
fitness. Furthermore, the results of the current study suggest that HMB supplementation
significantly improved the benefits of the 4-week HIIT program on some of the aerobic and
metabolic measures when compared to HIIT with the placebo.
The HIIT protocol used in the current study (Figure 1) resulted in a 4 to 11% increase in
aerobic performance measures (𝑉O2peak, Ppeak, Tmax; Table 2). In support, Smith et al. (2009)
reported a 9% to 11% increase in 𝑉O2peak and Tmax after 3-weeks of HIIT using a similar
protocol. In agreement, several studies have reported 7 to10% increases in 𝑉O2peak using HIIT
protocols in college-aged participants (Duffield, Edge, & Bishop, 2006; Helgerud et al., 2007;
Talanian, Galloway, Heigenhauser, Bonen, & Spriet, 2007). Although previous studies utilizing
this method of HIIT involved training 5 days per week, Jourkesh et al. (2011) also reported a
significant increase in Tmax after 3 weeks of fractal periodized HIIT and a significant increase in
𝑉O2peak after 6 weeks with training 3 times per week.
Furthermore, in the current investigation, supplementation with HMB, in addition to
HIIT, significantly increased 𝑉O2peak (Table 2, Figure 2) greater than training alone. The
present results are in agreement with Lamboley et al. (2007) who reported a 15% increase in
𝑉O2max after 5 weeks of a running HIIT program while supplementing 3grams per day of
Calcium β-hydroxy-β-methylbutyrate (CaHMB) in college age men and women. In contrast,
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previous studies, which involved supplementation of CaHMB while endurance training, found
no increase in 𝑉O2peak with 2 to 6 weeks of supplementation (Knitter et al., 2000; Vukovich &
Dreifort, 2001). In a cross-over design, Vukovich and Dreifort (2001), examined the effect of
CaHMB supplementation in endurance-trained cyclists, and reported no significant increase in
𝑉O2peak in these highly trained athletes, however, there was a significant increase (3.6%) in the
time reach to 𝑉O2peak (Tmax). The increase in Tmax observed in Vukovich and Dreifort (2001),
was smaller than our observed 8% increase in younger untrained men and women (Table 2). The
discrepancy between our study and previous endurance studies (Knitter et al., 2000; Vukovich &
Dreifort, 2001) examining HMB, could be due to the participants used in the investigation. It
has been suggested that active men and women who are unaccustomed to HIIT may benefit more
from HMB supplementation than trained athletes who are accustomed to HIIT (Lamboley et al.,
2007). The participants in the current study were unfamiliar with HIIT, which may explain why
our results were similar to Lamboley et al. and not Vukovich et al. who used trained endurance
athletes. However, Knitter et al. also examined individuals unaccustomed to HIIT, but reported
no additive effect of HMB supplement on endurance performance measures. Therefore, training
status and previous experience with HIIT could have influenced the current results while
explaining differences from previous investigations.
The type of training and manner in which it was conducted may have played an
additional role in the observed physiological adaptations. The differences reported by Lamboley
et al. and our findings versus other studies may be due to the fact that individualized HIIT
programs were developed based on each participant’s baseline fitness level and monitored
throughout the 28 days of training, while it was unclear what endurance program was used in
other studies(Knitter et al., 2000; Vukovich & Dreifort, 2001) as they did not describe in detail
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the exercise interventions. Therefore, the difference in results by Knitter (2000) and Vukovich et
al. (2001) in comparison to Lamboley et al. (2007) and our data may be that the training
programs were insufficient at stimulating physiological adaptation (J. M. Wilson et al., 2013; J.
M. Wilson et al., 2013; Zanchi et al., 2011).
Fatigue threshold measures, such as ventilatory threshold (VT), respiratory compensation
point (RCP), and onset of blood lactate accumulation (OBLA), have been used as non-invasive
measures of health, performance, and in the evaluation of the efficacy of endurance training
and/or nutritional supplementation (Lamboley et al., 2007; J. Stout et al., 2007; Zoeller, Stout,
O’kroy, Torok, & Mielke, 2007). Further, the measurement of specific fatigue thresholds during
a graded exercise test, like VT and RCP, may be useful for demarcating the heavy or severe
exercise intensity domains, respectively (Bergstrom et al. 2013). For example, VT has been
associated with exercise intensity that results in excessive CO2 production from the bicarbonate
buffering of hydrogen ions (Gaesser & Poole, 1996; Wasserman, Beaver, & Whipp, 1990), while
RCP has been associated with severe intensity exercise which leads to excessive minute
ventilation resulting from hyperkalemia (Bergstrom et al., 2013; Paterson et al., 1990). The
measurement of fatigue thresholds (VT, RCP), therefore, may provide possible mechanistic
explanation for aerobic performance changes from training or nutritional interventions.
Additionally, assessment of the exercise intensity domains, heavy (VT), severe (RCP) and
maximal (𝑉O2peak), during a graded exercise test may improve the sensitivity of detecting the
potential effects on aerobic performance from various exercise and or nutritional interventions
due to different mechanisms.
In the current study, the four-week HIIT program resulted in a 6.3% increase in power
output at ventilatory threshold (PVT) (Table 2) which is similar to Smith et al. (2009) who
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reported a 10.2 % increase using a comparable three-week HIIT cycling protocol in untrained
college aged men. In addition, our study demonstrated an 8.6% increase in RCP which was very
similar to the changes reported by Lamboley et al (2007) of an 8.5% increase from 5 weeks of
HIIT on a treadmill. Our data, along with Smith et al. (2009) and Lamboley et al (2007),
supports previous studies that demonstrate HIIT consistently improves aerobic performance
measures (Berger, Campbell, Wilkerson, & Jones, 2006; Eddy, Sparks, & Adelizi, 1977;
Helgerud et al., 2007).
The addition of HMB to the four weeks of HIIT (HMB-HIIT) resulted in a ~14%
increase in VT which was significantly greater than HIIT alone (Table 2, Figure 7). However,
there was no difference between HMB-HIIT and HIIT groups for changes in RCP (Table 2,
Figure 5). While our findings are similar to percent change (+11.1%) in VT as a previous study
reported, Lamboley et al. (2007) discovered no significant difference between HMB-HIIT and
HIIT groups. Conversely, Lamboley et al. (2007) reported significantly greater changes in RCP
for HMB-HIIT compared to HIIT, whereas the current investigation resulted in similar changes
between groups. Furthermore, Vukovich and Dreifort (2001) reported a 9.1% increase in OBLA
after two weeks of CaHMB supplementation in elite cyclists. Previous researchers have used
OBLA as a method to identify the crossover point between moderate and heavy exercise
intensities denoted by blood lactate concentrations greater than 4 millimoles per liter during an
incremental exercise test (Heck et al., 1985). With previous evidence supporting OBLA and VT
as fatigue thresholds representing similar exercise domains, the increases in exercise intensity at
OBLA (+9.1%) reported by Vukovich and Dreifort (2001) and the increase in VT (+14%)
observed in our study (Table 2) may reflect similar physiological adaptations. Our results, along
with Vukovich and Dreifort (2001) and Lamboley et al. (2007), suggest that HMB may augment
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the beneficial effects of HIIT on aerobic performance by increasing fatigue threshold measures
that reflect the physiological response to moderate and/or severe intensity exercise.
The observed physiological changes in aerobic performance from HIIT have been shown
to improve 𝑉O2peak, muscle buffering capacity, and whole body fat oxidation (Edge, Bishop, &
Goodman, 2006; Laursen & Jenkins, 2002; Weston, Zhou, Weatherby, & Robertson, 1997).
Further, the improved aerobic power associated with HIIT has been linked to an up-regulation of
glycolytic enzymes, as well as, increased mitochondrial density and blood flow (Henriksson,
1992; Krustrup, Söderlund, Mohr, & Bangsbo, 2004). Recently, it has been suggested that HMB
supplementation may improve fatty acid oxidation, adenosine monophosphate kinase (AMPK),
Sirt1, and Sirt3 activity in muscle cells (Bruckbauer et al., 2012; Pinheiro et al., 2012). Sirt1,
Sirt3, and AMPK have been shown to augment mitochondrial biogenesis, lipolysis, energy
metabolism and the reactive oxygen defense system (Hardie & Sakamoto, 2006; Verdin,
Hirschey, Finley, & Haigis, 2010). In support, Stancliffe (2012) reported that HMB mediated
mitochondrial biogenesis in murine myotubes. Additionally, Pinheiro et al. (2012) reported that
28 days of CaHMB administration in male Wistar rats resulted in significantly increased
intramuscular ATP and glycogen content. While speculative, HMB supplementation may have
enhanced the effects of HIIT by improving mitochondrial biogenesis, fat oxidation, and energy
metabolism and capacity. However, more research is needed to support these proposed
mechanisms in humans.
In conclusion, our findings reinforce the use of HIIT as an effective training stimulus for
improving aerobic performance. In addition, the use of HMB supplementation, in combination
with HIIT, appeared to result in greater changes in 𝑉O2peak and VT than HIIT alone. While
more research is needed, the current investigation suggests that in college age men and women,
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the use of HMB supplementation may enhance the benefits of HIIT on aerobic performance
measures.
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University of Central Florida Institutional Review Board
Office of Research & Commercialization
12201 Research Parkway, Suite 501
Orlando, Florida 32826-3246
Telephone: 407-823-2901, 407-882-2901 or 407-882-2276
www.research.ucf.edu/compliance/irb.html

Notice that UCF will Rely Upon Other IRB for Review and Approval
From :

UCF Institutional Review Board
FWA00000351, IRB00001138

To

Edward H. Robinson IV

:

Date :

August 19, 2013

IRB Number: SBE-13-09475
Study Title: The effects of ß-Hydroxy-ß-methylbutyrate Free Acid Gel and High-Intensity Interval Training on
Quadriceps Muscle Architecture and Quality, Neuromuscular Economy, and Metabolic Performance in Recreationally
Trained Individuals
Dear Researcher:
The research protocol noted above was reviewed by the University of Central Florida IRB Chair designated Reviewer on
August 19, 2013. The UCF IRB accepts the New England Institutional Review Board’s review and approval of this
study for the protection of human subjects in research. The expiration date will be the date assigned by the New
England Institutional Review Board and the consent process will be the process approved by that IRB.
This project may move forward as described in the protocol. It is understood that the New England IRB is the IRB of
Record for this study, but local issues involving the UCF population should be brought to the attention of the UCF IRB
as well for local oversight, if needed.
All data, including signed consent forms if applicable, must be retained in a locked file cabinet for a minimum of five
years (six if HIPAA applies) past the completion of this research. Additional requirements may be imposed by your
funding agency, your department, or other entities. Access to data is limited to authorized individuals listed as key study
personnel.
Failure to provide a continuing review report for renewal of the study to the New England IRB could lead to
study suspension, a loss of funding and/or publication possibilities, or a report of noncompliance to sponsors or
funding agencies. If this study is funded by any branch of the Department of Health and Human Services
(DHHS), an Office for Human Research Protections (OHRP) IRB Authorization form must be signed by the
signatory officials of both institutions and a copy of the form must be kept on file at the IRB office of both
institutions.
On behalf of Sophia Dziegielewski, Ph.D., L.C.S.W., UCF IRB Chair, this letter is signed by:
Signature applied by Patria Davis on 08/19/2013 10:41:19 AM EDT

IRB Coordinator
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August 13, 2013
Edward H. Robinson, IV
University of Central Florida
12494 University Boulevard
Orlando, FL 32816
Re:

(IRB# 13-257): SBE-13-09475: "The  Effects  of  β-Hydoxy- β-Methylbutyrate Free Acid Gel and High-Intensity
Interval Training on Quadriceps Muscle Architecture and Quality, Neuromuscular Economy and Metabolic
Performance in Recreationally Trained Individuals"

This is to inform you that New England Institutional Review Board (NEIRB), via expedited review (Thursday Board), has
approved the above-referenced research protocol and the participation of the above-referenced investigative site in the research.
The approval period is 8/13/2013 to 7/28/2014. Your study number is 13-257. Please be sure to reference either this
number or the name of the principal investigator in any correspondence with NEIRB.
Continued approval is conditional upon your compliance with the following requirements:


A copy of the Informed Consent Document, NEIRB version 1.0, approved on 8/13/2013 is enclosed. Only NEIRBapproved informed consent documents should be used. It must be signed by each subject prior to initiation of any protocol
procedures. In addition, each subject must be given a copy of the signed consent form.



The following must be promptly reported to NEIRB: changes to the study site, and all unanticipated problems that may
involve risks or affect the safety or welfare of subjects or others, or that may affect the integrity of the research.



Approval is valid for enrollment of the number of subjects indicated on your submission form. If you anticipate enrolling
more than this number of subjects, NEIRB approval must be obtained prior to exceeding the approved enrollment number.



All protocol amendments and changes to approved research must be submitted to the IRB and not be implemented until
approved by the IRB except where necessary to eliminate apparent immediate hazards to the study subjects.



Compliance with all federal and state laws pertaining to this research, and with NEIRB’s  SOPs.



The enclosed subject materials (PAR-Q and You Questionnaire and QConfidential Medical and Acitvity History
uestionnaire) have been approved. The enclosed recruitment advertisement (Print Ad) has been conditionally approved.
Please make the indicated revisions and re-submit it to NEIRB for final approval. Advertisements, letters, internet
postings and any other media for subject recruitment must be submitted to NEIRB and approved prior to use. Please refer
to NEIRB Guidelines for Recruitment and Advertising, available at www.neirb.com.



All deaths, life-threatening problems or serious or unexpected adverse events, whether related to the study article or not,
must be reported to the IRB. The Serious Adverse Event Form is available at www.neirb.com.



Any and all necessary FDA approvals must be received prior to your initiation of the trial. If this study is being conducted
under an IDE, a copy of the FDA IDE approval letter must be submitted to NEIRB.



The study cannot continue after 7/28/2014 until re-approved by NEIRB. A Study Renewal Report must be completed and
returned to NEIRB prior to the expiration of the approval period.

85 Wells Avenue . Suite 107 . Newton, MA 02459
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When the study is completed, terminated, or if it is not being renewed - complete and submit a Study Completion Report to
NEIRB. The Study Completion Report can be accessed via the NEIRB website at www.neirb.com.

Shana R. Ross, MCJ, CIM, CIP
Lead Administrator

Copy:

NEIRB Chair
Enclosures

85 Wells Avenue . Suite 107 . Newton, MA 02459
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The effects of β-Hydroxy-β-methylbutyrate Free Acid Gel and High-Intensity Interval
Training on Quadriceps Muscle Architecture and Quality, Neuromuscular Economy, and
Metabolic Performance in Recreationally Trained Individuals
Informed Consent
Principal Investigator(s):

Edward H. Robinson IV, M.A./M.S.
Jeffrey R. Stout, Ph.D.

Sponsor:

Metabolic Technologies Inc.

Investigational Site(s):

University of Central Florida
College of Education and Human Performance
Sport and Exercise Science

Introduction: Researchers at the University of Central Florida (UCF) study many topics. To do
this we need the help of people who agree to take part in a research study. You are being asked
to take part in a research study that will include 40 men and women at UCF. You have been
asked to take part in this research study because you are an active young adult who routinely
participates in recreationally training. You must be between 18 and 35 years of age to be
included in this research study.
The principle investigators conducting the research are Edward H. Robinson IV, and Dr. Jeffrey R.
Stout. They will be supported by Dr. Jay R. Hoffman, Dr. Maren S. Fragala (Sport and Exercise
Science in the College of Education), and Dr. Leonardo Oliveira (Sports Medicine Physician at
UCF and medical monitor of the study).

1 of 7
NEIRB ICF version 1.0
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What you should know about a research study:
 Someone will explain this research study to you.
 A research study is something you volunteer for.
 Whether or not you take part is up to you.
 You should take part in this study only because you want to.
 You can choose not to take part in the research study.
 You can agree to take part now and later change your mind.
 Whatever you decide it will not be held against you.
 Feel free to ask all the questions you want before you decide.
1. Purpose of the research study:
We will examine two factors in this study:
1) How exercise that involves repeated short-to-long bouts of high-intensity
exercise interspersed with recovery periods, also know as, high intensity
interval training (HIIT) effects cardiovascular and muscular adaptations to this
form of endurance training.
2) How supplementation with the free acid form β-Hydroxy-β-methylbutyrate
(HMB-FA)—a chemical found naturally in the body and in some of the foods
that we eat—effects the cardiovascular and muscular adaptations to this form
of endurance training.
Testing location and time requirements:
All testing will be conducted in the Human Performance Lab (HPL) in the College of
Education and Human Performance building at the University of Central Florida. All
measures and tests are conducted for research purposes only. The results will not be
used to diagnose any illness or disease, and will not provide any meaningful
information to your physician.
Time requirements: We expect that you will be in this research study for
approximately 6 weeks and will consist of 17 visits to the HPL. The first visit will last
approximately an hour, the second and third visits about an hour and a half, and the
training visits, 3 per week for 4 weeks, will last less than 30 minutes, and the final two
testing visits will last approximately an hour and a half.
What you will be asked to do in the study:
Upon being admitted to the study you will be assigned a subject number. Each subject
number will be associated with one of three groups: a control group (CTL), an HIIT
only group (HIIT) or a group which will take the amino acid metabolite HMB and
perform HIIT (HMB-HIIT). Determination of the group associated with each subject
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number will occur by randomization (similar to flipping a coin). Of the 40 subjects
that will be recruited for the study, 10 subjects will be assigned to CTL and 15 to each
of the training groups. You will be unable to change your assigned study group to a
different study group.
Individuals assigned to CTL will undergo testing on visits 2 and 3. They will then
be asked to continue their normal exercise routine for 4 weeks and will undergo posttesting (visits 16 and 17) after this time period. Participants in the HIIT and HMBHIIT groups will be asked on training days, to consume 1 gram HMB-FA or placebo 30
min prior to training, 1gram HMB-FA or placebo 1 hour post training, and 1gram
HMB-FA or placebo 3 hours post training. On non-training days, individuals will
consume HMB-FA or placebo 3 times per day (8am, 12pm and 4pm).
Preliminary Visits (3):
Visit 1: You will be asked to read and sign this consent form before any study-related
procedures are performed. During this first visit, the following will be done:
Complete the Physical Activity Readiness Questionnaire (PAR-Q)
Complete the self-reported medical and activity history questionnaire
Your age, race and gender will be collected
Your body measurements (height, weight) will be measured
You will be given a 3-day food log to complete prior to visit 3. The dietary intake on
this food log will be considered your pre-testing diet and you will be asked to maintain
this style of diet during all experimental trials.
Visit 2: The second visit will take place at least 24 hours following visit 1. On this
visit:
You will have an ultrasound performed on the quadriceps in your leg. For this, you
will be asked to lie flat on your back on an examination table with your legs extended.
A lubricated probe will be placed over your thigh to collect information about your
muscle (cross-sectional area, fascicle length, echo intensity, muscle thickness). These
images will provide the ability to rate the quality of your muscle and how the muscle
quality may change after the training intervention.
You will be outfitted with surface electrodes over the vastus lateralis muscles in your
quadriceps to measure electromyography (EMG). You will also be asked to perform a
maximal leg extension to record a maximal EMG signal. The EMG signal will also be
collected during the VO2peak testing.
You will also be asked to perform a VO2max test, which will include pedaling on the
cycle ergometer at increasing resistance until you can no longer continue. Expired
gases will be collected via a mask to determine oxygen uptake, respiratory quotient,
energy expenditure and ventilatory threshold.
Visit 3: The third visit will take place no sooner than 48hrs following visit 2. On this
visit:
You will have a blood sample taken. The total volume of blood that will be obtained
during this study will be <25 ml. To put the total volume of blood being drawn in
proper perspective, one pint (475 ml) of blood is typically drawn when donating
blood. All blood draws will be conducted under sterile conditions. As an additional
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safeguard in preventing contamination new disposable gloves will be used for all
blood draws. The discomforts associated with the blood drawing procedures are
minimal, but sometimes bruising and infection may occur, and your arm might
become sore. This soreness usually resolves in a few days. If it persists, contact your
doctor.
All blood samples collected will be frozen until analysis. However, blood samples
obtained will only be used for this specific study and any leftover blood will be
discarded following analysis.
You will have a dual energy x-ray absorptiometry (DEXA) scan performed to assess
total and regional body composition. The DEXA machine consists of a padded table
with a mechanical arm that uses low dose x-ray to measure muscle, adipose and bone
mass. You will be asked to lie flat on your back, with your arms at your sides, legs
extended and feet together. The mechanical arm of the DEXA will then pass slowly
over your body, without contact. The full body scan will last about 15 minutes.
You will perform a 3-minute critical power test. After a self-selected warm-up, you
will begin with 60 seconds of unloaded cycling at 90 rpm, followed by an all-out threeminute effort with resistance being set as a function of pedaling rate. The resistance
will be adjusted during the all-out effort using the linear mode on the cycle ergometer
that sets the power output at 50% of the difference between the ventilator threshold
and peak power output assessed during the graded exercise test. EMG assessment
will also be conducted during this test, electrode placement will be the same as
previously described.
Training Visits (12):
If you are in the HIIT or HMB-HIIT group, you will complete 4 weeks of high
intensity interval training (HIIT). The training will occur in the Human Performance
Lab 3 times per week for 4 weeks with alternating training sessions of sub maximal
and supramaximal workloads. Your training load will be determined as a percentage
of the peak power output from the graded exercise test. Each training session with a 5minute warm up at 50 W, followed by a protocol of 5 or 6 2-minute exercise bouts
(total time 15-17 minutes) at a predetermined percentage of VO2peak. There will be 1
minute of complete rest in between exercise bouts during which you will be asked
about your perceived readiness to continue exercise.
Post-training Testing visits (2):
These visits will mirror visit 2 and visit 3.
Funding for this study: This research study is being funded by Metabolic
Technologies Inc.
Risks:
The risks involved with this study are minimal, but may include musculoskeletal
injuries occurring during the training protocol. These injuries include muscle strains
and pulls. However, the interval training portion of the study is similar to a hard
4 of 7
Approved by NEIRB on 8/13/2013
NEIRB ICF version 1.0

	
  

70	
  

training session that experienced recreationally trained individuals have previously
performed during training. The risks associated with the blood draw include some
momentary pain at the time of the draw, but other discomfort should be minimal. It is
also possible for a bruise to develop at the site or for individuals to report dizziness
and faint after the blood is drawn. It is also rare, but possible to develop minor
infections and pain after the blood draw. To minimize the risks, the skin area at the
site of the blood draw will be cleaned and prepared with a disinfectant wipe before
the hypodermic is inserted. In addition, the blood draw will occur while the
participant is lying supine. There are no risks or discomforts associated with any of
the ultrasound measures. Procedures such as DEXA used during this research study
involve X-rays. However, the cumulative radiation exposure from these tests is
considered small and is not likely to adversely affect you. Additionally all testing and
training will be overseen by individuals certified in CPR and AED. An AED is located in
the building where testing and training will occur.
You should report any discomforts or injuries to one of the principle investigators
Edward Robinson, 407-823-2367, ned.robinson@ucf.edu or Dr. Jeff Stout, 407-8232367, jeffrey.stout@ucf.edu.
Benefits
There are no direct benefits to participants.
Compensation or payment:
Upon completion of the study, you will receive a $100 payment for participation. No
compensation will be provided if you are unable to complete the study.
Confidentiality: The results of this study will be published as a group as part of a
scientific publication. No individual results will be published or shared with any
person or party. All information attained from the medical and activity questionnaire
or performance tests will be held in strict confidence. Individual results will remain
confidential and only be relayed to the subject upon request. All medical and activity
questionnaires, as well as data collection sheets will be kept in a locked cabinet during
and following the study. All information will be destroyed 5 years from the end of the
study and not used for other research purposes. Participant folders and blood storage
tubes will be marked with an I.D. number to protect against a breach of confidentiality
and the ID number will be removed upon disposal. Participant names and I.D.
numbers will be stored apart from the blood samples; the identifiers will be removed
from the samples and destroyed when the samples are disposed.
Study contact for questions about the study or to report a problem: If you have
questions, concerns, or complaints, or think the research has hurt you, please contact
Ned Robinson or Dr. Jeff Stout, Human Performance Laboratory, Sport and Exercise
Science (407) 823-2367 or by email at ned.robinson@ucf.edu or
Jeffrey.stout@ucf.edu.
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IRB contact about your rights in the study or to report a complaint: Research at
the University of Central Florida involving human participants is carried out under the
oversight of the New England Institutional Review Board (NEIRB). For information
about the rights of people who take part in research, please contact: New England
Institutional Review Board, at 1-800-232-9570. You may also talk to them for any of
the following:
Your questions, concerns, or complaints are not being answered by the research team.
You cannot reach the research team.
You want to talk to someone besides the research team.
You want to get information or provide input about this research.
Withdrawing from the study:
You have the right to discontinue participation without penalty, regardless of the
status of the study. Your participation in the study may also be terminated at any time
by the researchers in charge of the project. This could be based upon your refusal to
follow study instructions or follow the study protocol. Depending upon when you
withdraw, you may be able to receive compensation for the time that you did
participate.	
  	
  Please	
  refer	
  back	
  to	
  the	
  “Compensation	
  or	
  Payment”	
  section	
  on	
  the	
  top	
  of	
  
this page.
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VOLUNTEER'S STATEMENT:
I have been given a chance to ask questions about this research study. These questions have been
answered to my satisfaction. I may contact Edward Robinson if I have any more questions about
taking part in this study. Edward Robinson or the company he/she is employed by is being paid by the
sponsor for my participation in this study.
I understand that my participation in this research project is voluntary. I know that I may quit the
study at any time without harming my future medical care or losing any benefits to which I might be
entitled. I also understand that the investigator in charge of this study may decide at any time that I
should no longer participate in this study.
If I have any questions about my rights as a research subject in this study I may contact:
New England Institutional Review Board
Telephone: 1-800-232-9570
By signing this form, I have not waived any of my legal rights.
I have read and understand the above information. I agree to participate in this study. I understand
that I will be given a copy of this signed and dated form for my own records.
__________________________________
Study Participant (signature)

__________
Date

__________________________________
Print  Participant’s  Name
__________________________________
Person who explained this study (signature)

__________
Date
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APPENDIX D
MEDICAL HISTORY QUESTIONNAIRE
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Human Performance Laboratory
University of Central Florida

Confidential Medical and Activity History Questionnaire
Participant #__________
When was your last physical examination? _________________________________
1. List any medications, herbals or supplements you currently take or have taken
the last month:
Medication
_______________________
_______________________
_______________________
_______________________

Reason for medication
_______________________
_______________________
_______________________
_______________________

2. Are you allergic to any medications? If yes, please list medications and reaction.

3. Please list any allergies, including food allergies that you may have?

4. Have you ever been hospitalized? If yes, please explain.
Year of hospitalization
_______________________
_______________________
_______________________

Reason
_______________________
_______________________
_______________________

5. Illnesses and other Health Issues
List any chronic (long-term) illnesses that have caused you to seek medical care.

1
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Human Performance Laboratory
University of Central Florida

Have you ever had (or do you have now) any of the following. Please circle
questions that you do not know the answer to.
Sickle cell anemia
Cystic fibrosis
Water retention problems
Heart pacemaker
Epilepsy
Convulsions
Dizziness/fainting/unconsciousness
Asthma
Shortness of breath
Chronic respiratory disorder
Chronic headaches
Chronic cough
Chronic sinus problem
High blood pressure
Heart murmur
Heart attack
High cholesterol
Diabetes mellitus or insipidus
Rheumatic fever
Emphysema
Bronchitis
Hepatitis
Kidney disease
Bladder problems
Tuberculosis (positive skin test)
Yellow jaundice
Auto immune deficiency
Anemia
Endotoxemia
Thyroid problems
Hyperprolactinemia
Anorexia nervosa
Bulimia
Stomach/intestinal problems
Arthritis
Back pain
Gout
Hepatic encephalopathy
Mania
Hypermania
Monosodium glutamate hypersensitivity
Seizure disorders

yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes

no
no
no
no
no
no
no
no
no
no
no
no
no
no
no
no
no
no
no
no
no
no
no
no
no
no
no
no
no
no
no
no
no
no
no
no
no
no
no
no
no
no
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Human Performance Laboratory
University of Central Florida

Any others (specify):__________________________________________
___________________________________________________________
___________________________________________________________
Do you smoke cigarettes or use any other tobacco
products?
yes
no
Do you have a history of drug or alcohol
dependency?
yes
no
Do you ever have any pain in your chest?
yes
no
Are you ever bothered by racing of your heart?
yes
no
Do you ever notice abnormal or skipped heartbeats? yes
no
Do you ever have any arm or jaw discomfort, nausea,
Or vomiting associated with cardiac symptoms?
yes
no
Do you ever have difficulty breathing?
yes
no
Do you ever experience shortness of breath?
yes
no
Do you ever become dizzy during exercise?
yes
no
Are you pregnant?
yes
no
Is there a chance that you may be pregnant?
yes
no
Have you ever had any tingling or numbness in
your arms or legs?
yes
no
Has a member of your family or close relative
died of heart problems or sudden death before
the age of 50?
yes
no
Has a health care practitioner ever denied or
restricted your participation in sports for any
problem
yes
no
If yes, please explain: _____________________________________________
_______________________________________________________________
Are you presently taking any nutritional supplements or ergogenic aids? (if yes, please
detail. ________________________________________________________________
________________________________________________________________________
______________________________________________________________________
______________________________________________________________________
______________________________________________________________________
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APPENDIX E
PHYSICAL ACTIVITY READINESS QUESTIONNAIRE

	
  

78	
  

PAR-Q & YOU

Physical Activity Readiness
Questionnaire - PAR-Q
(revised 2002)

(A Questionnaire for People Aged 15 to 69)
Regular physical activity is fun and healthy, and increasingly more people are starting to become more active every day. Being more active is very safe for most
people. However, some people should check with their doctor before they start becoming much more physically active.
If you are planning to become much more physically active than you are now, start by answering the seven questions in the box below. If you are between the
ages of 15 and 69, the PAR-Q will tell you if you should check with your doctor before you start. If you are over 69 years of age, and you are not used to being
very active, check with your doctor.
Common sense is your best guide when you answer these questions. Please read the questions carefully and answer each one honestly: check YES or NO.
YES

NO

If
you
answered

1.

Has your doctor ever said that you have a heart condition and that you should only do physical activity
recommended by a doctor?

2.

Do you feel pain in your chest when you do physical activity?

3.

In the past month, have you had chest pain when you were not doing physical activity?

4.

Do you lose your balance because of dizziness or do you ever lose consciousness?

5.

Do you have a bone or joint problem (for example, back, knee or hip) that could be made worse by a
change in your physical activity?

6.

Is your doctor currently prescribing drugs (for example, water pills) for your blood pressure or heart condition?

7.

Do you know of any other reason why you should not do physical activity?

YES to one or more questions
Talk with your doctor by phone or in person BEFORE you start becoming much more physically active or BEFORE you have a fitness appraisal. Tell
your doctor about the PAR-Q and which questions you answered YES.
those which are safe for you. Talk with your doctor about the kinds of activities you wish to participate in and follow his/her advice.

NO to all questions

DELAY BECOMING MUCH MORE ACTIVE:

If you answered NO honestly to all PAR-Q questions, you can be reasonably sure that you can:

a cold or a fever – wait until you feel better; or
start becoming more active.

safest and easiest way to go.
that you can plan the best way for you to live actively. It is also highly recommended that you
have your blood pressure evaluated. If your reading is over 144/94, talk with your doctor
before you start becoming much more physically active.

PLEASE NOTE: If your health changes so that you then answer YES to
any of the above questions, tell your fitness or health professional.
Ask whether you should change your physical activity plan.

Informed Use of the PAR-Q: The Canadian Society for Exercise Physiology, Health Canada, and their agents assume no liability for persons who undertake physical activity, and if in doubt after completing
this questionnaire, consult your doctor prior to physical activity.

No changes permitted. You are encouraged to photocopy the PAR-Q but only if you use the entire form.
NOTE: If the PAR-Q is being given to a person before he or she participates in a physical activity program or a fitness appraisal, this section may be used for legal or administrative purposes.

"I have read, understood and completed this questionnaire. Any questions I had were answered to my full satisfaction."
NAME ________________________________________________________________________
SIGNATURE _______________________________________________________________________________

DATE______________________________________________________

SIGNATURE OF PARENT _______________________________________________________________________
or GUARDIAN (for participants under the age of majority)

WITNESS ___________________________________________________

Note: This physical activity clearance is valid for a maximum of 12 months from the date it is completed and
becomes invalid if your condition changes so that you would answer YES to any of the seven questions.
© Canadian Society for Exercise Physiology www.csep.ca/forms
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Volunteers Needed for
Research Study
Want%to%learn%a%new%way%to%endurance%train?%
%
We%need%participants%for%a%research%study:%
%“The%effects%of%β9Hydroxy9β9methylbutyrate%Free%Acid%Gel%and%High9Intensity%Interval%Training%on%
Quadriceps%Muscle%Architecture%and%Quality,%Neuromuscular%Economy,%and%Metabolic%Performance%
in%Recreationally%Trained%Individuals”%
%

%
Description%of%Project:!We!are!investigating!the!effect!of!how!a!new!version!of!the!
sport!supplement!HMB!and!high9intensity!interval!training!might!change!the!
musculature!of!the!leg!and!improve!cardiovascular!and!neuromuscular!performance.!
!

Who%is%Eligible?%Men!and!Women!between!the!Ages!of!18935!who!regularly!Run!or!
Bike!
!

What%will%you%be%asked%to%do?!!Complete!2!Pre9!and!2!Post9Testing!sessions.!!4!weeks!
of!High!Intensity!Interval!Training!on!a!stationary!bike!(approx.!30!min!per!session)!
!
Compensation:!Participants!will!receive!$100!for!completion!of!the!study.!
!

To!learn!more,!contact!the!principal!investigator!of!the!study,!Ned!Robinson,!!
at!407982392367!or!humanperformancelab@ucf.edu.!
This!research!is!conducted!under!the!direction!of!Dr.!Jeffrey!Stout,!Educational!and!Human!Sciences!Department.!
!

Ned!Robinson!
407982392367!
humanperformancelab@ucf.edu!

Ned!Robinson!
407982392367!
humanperformancelab@ucf.edu!

Ned!Robinson!
407982392367!
humanperformancelab@ucf.edu!

Ned!Robinson!
407982392367!
humanperformancelab@ucf.edu!
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Ned!Robinson!
407982392367!
humanperformancelab@ucf.edu!

Ned!Robinson!
407982392367!
humanperformancelab@ucf.edu!

Ned!Robinson!
407982392367!
humanperformancelab@ucf.edu!

Ned!Robinson!
407982392367!
humanperformancelab@ucf.edu!

Ned!Robinson!
407982392367!
humanperformancelab@ucf.edu!

Ned!Robinson!
407982392367!
humanperformancelab@ucf.edu!

Ned!Robinson!
407982392367!
humanperformancelab@ucf.edu!

Ned!Robinson!
407982392367!
humanperformancelab@ucf.edu!
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